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ABSTRACT 
Kyla Welch Taylor: Associations between Personal Care Product Use Patterns and Breast Cancer 
Risk in the Sister Study  
 (Under the direction of Melissa Troester) 
Background: Among women in the United States, breast cancer is the second leading cancer-
related cause of death. It is hypothesized that certain chemicals in personal care products may 
increase risk of breast cancer. The primary aims of this study were to use a data-centered 
approach to classify complex patterns of exposure to personal care products, understand how 
these patterns vary according breast cancer risk factors, and evaluate whether patterns of beauty, 
hair, or skin-related personal care products or individual products were associated with breast 
cancer. 
Methods: Limiting the sample to non-Hispanic blacks and whites (N=47,019), latent class 
analysis (LCA) was used to identify groups of individuals with similar patterns of personal care 
product use based on responses to survey questions. Personal care products were categorized into 
three product types (beauty, hair, and skincare products) and separate latent classes were 
constructed for each type. Adjusted prevalence differences (PD) were calculated to estimate the 
association between known and suspected breast cancer risk factors and patterns of personal care 
product use. Multivariable Cox proportional hazards models were used to estimate hazard ratios 
(HRs) and 95% confidence intervals (95% CIs) for the association between product use and 
breast cancer risk.  
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Results: Latent class analysis (LCA) was used to reduce data dimensionality across 48 
individual personal care product use questions and to identify groups of individuals with similar 
patterns of product use. Three latent classes were identified for both the beauty and hair product 
groups; the skincare product group had four classes. Among white women, those classified as 
‘moderate’ and ‘frequent’ users of beauty products had increased risk of breast cancer relative to 
‘infrequent users’ (HR=1.12; 95% CI: 1.00-1.27 and HR=1.15; 95% CI: 1.02-1.30).  ‘Frequent’ 
users of skincare products also had increased risk of breast cancer relative to ‘infrequent users’ 
(HR=1.13; 95% CI: 1.00-1.29).  
Conclusions: Relative to individual product use questions, latent class variables capture complex 
patterns of personal care product usage. This work generates novel hypotheses for breast cancer 
risk.
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CHAPTER 1: BACKGROUND 
1.1. Breast Cancer Biology and Epidemiology  
Breast cancer is the second leading cancer-related cause of death among women in the 
United States. Only lung cancer accounts for more cancer deaths in women [1, 2]. The American 
Cancer Society estimates that in 2014 there were approximately 232,670 new cases of invasive 
breast cancer diagnosed and approximately 40,000 breast cancer-caused deaths [2]. 
1.1.1. Genetic Risk Factors 
It is estimated that 5% to 10% of breast cancer cases are hereditary [3, 4]. Among 
hereditary breast cancers, 20 to 25% are accounted for by high penetrance BRCA1 and BRCA2 
gene mutations [5, 6]. These gene mutations are associated with a 10-fold increase in breast 
cancer risk but are rare [7]. Intermediate-penetrance genetic mutations in genes involved in DNA 
repair such as ATM, CHEK2, BRIP1, and PALB2 increase breast cancer risk about 2- to 3-fold 
[8]. Low-penetrance, common single nucleotide polymorphisms (SNPs) are associated with low 
personal risk of breast cancer but are prevalent enough in the population to be significant on a 
public health level (e.g. SNPs found in FGFR2, TNRC9, MAP3K1, or LSP1) [8-10].  
Breast cancer risk is higher among women who have one or more first-degree family members 
with the disease. A woman with one first-degree relative (e.g., mother or sister) with breast 
cancer has approximately double the risk of breast cancer compared to a woman with no family 
history of breast cancer [11, 12]. Compared to women without a family history, having two first-
degree relatives who have been diagnosed with breast cancer increases a woman’s risk about 3-
fold; having three or more first-degree relatives diagnosed with breast cancer increases risk
2 
 
4-fold. However, the vast majority of women diagnosed with breast cancer, over 85%, do not 
have a family history [9, 12]. 
1.1.2. Established Non-Genetic Risk Factors 
Established non-genetic risk factors for breast cancer include age, reproductive history 
(e.g., late age at first birth, nulliparity or low parity, late menopause, early menarche, and little or 
no lactation), hormone replacement therapy use and recent oral contraceptive use, higher adult 
body mass index (BMI), and alcohol consumption. The evidence for each of these associations is 
summarized below.  
Age 
Breast cancer risk increases significantly with age. As a person grows older, tissue 
accumulates they experience more opportunities or genetic damage (e.g., mutations) in their bod. 
According to data from the Surveillance, Epidemiology, and End Results (SEER) Program [13], 
rates of breast cancer are lowest in women under 40 years.  Rates begin to increase after age 40 
and are highest in women over age 70 [2]. Between 2006 and 2010, 79% of new cases and 88% 
of breast cancer deaths occurred in women 50 years of age and older; the median age at the time 
of breast cancer diagnosis was 61 years [2, 13]. Breast cancer incidence among women ages 80 
to 85 years old is 15 times higher than in women ages 30 to 35 years old [14]. Women who are 
diagnosed with breast cancer at a younger age (≤35-40 years) are more likely to have more 
aggressive breast cancers that are related to BRCA1 or BRCA2 gene mutations [15].  
Race and Ethnicity 
In the United States, the highest breast cancer incidence rate of any racial or ethnic group 
is among non-Hispanic white women [16]. Hormonally responsive, luminal tumors are the 
predominant breast cancer subtype for non-Hispanic white and African American women in the 
United States, particularly among postmenopausal women [16]. However, pre-menopausal 
 
 
3 
 
African American women have higher incidence before age 40 and have higher prevalence of 
basal-like breast cancers [17, 18]. African American women are also more likely to die from 
breast cancer than white women [19]. Hispanic women have lower incidence rates and lower 
mortality rates than white women and African American women [2]. Asian/Pacific Islander 
women have the lowest incidence and mortality rates [20]. The reasons for ethnic disparities are 
not entirely clear, but likely reflect diet, lifestyle, and access to medical care [21].  
Reproductive Risk and Protective Factors 
Risk of developing breast cancer is strongly linked to reproductive factors, which 
characterize exposure to sex hormones. Many reproductive risk factors are associated with 
exposure to estradiol, progesterone, systemic circulating estrogen levels, and other hormones 
[22, 23]. Reviews of the epidemiologic literature have reported that that early menarche (before 
age 12), late menopause (after age 55), low parity, late age at first birth (after age 30), and 
shorter duration of breastfeeding (less than 12 months) are associated with an increased risk of 
breast cancer [24, 25]. Women who experience risk factors such as early menarche and late 
menopause may have an increased risk of breast cancer due to a longer lifetime exposure to the 
hormones estrogen and progesterone [26]. The literature also suggests that the protective effect 
of earlier first full-term pregnancy and longer duration of breastfeeding may result from the 
reduced effect of circulating hormones on breast tissue after pregnancy [25] and reduction of a 
woman's total number of lifetime menstrual cycles [2].  However, reproductive factors have 
many different effects on biology and lifestyle and therefore the mechanisms are complex and 
remain uncertain. 
Oral Contraceptives and Post-menopausal Hormone Replacement Therapy 
Oral contraceptives (OC) and post-menopausal hormone replacement therapy (HRT) are 
estrogen, progesterone, or estrogen and progesterone combined regimens. The use of OCs is 
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associated with increased breast cancer risk in current and recent users; however the effect 
diminishes 10 years after stopping use [27]. The use of HRT (estrogen-progesterone) is 
associated with increased breast cancer risk among post-menopausal women; however the effect 
diminishes 5 years after cessation of use [28]. A pooled analysis of 51 epidemiologic studies of 
around 54,000 postmenopausal women [28] reported that the relative risk of breast cancer 
diagnosis increased in relation to duration of HRT use (2.3% per year; 95% CI: 1.1, 3.5%). 
Among current or recent users, defined as use within the past 5 years, who had used HRT for 5 
or more years, the relative risk of breast cancer was 1.35 (95% CI: 1.21, 1.49). However past 
users (>5 years since cessation of HRT use) had no significant increase in relative risk of breast 
cancer that was related to duration of use [28].   
Alcohol 
Consumption of alcoholic beverages is a well-established risk factor for breast cancer 
[29].  Meta-analyses report that women who consume one alcohol beverage per day have an 
increased risk, between 7% and 12%, of breast cancer when compared to non-drinkers [30-32]. 
Compared with non-drinkers, light drinkers (up to one drink per day, 1.5 units) have a smaller 
increased risk (5%) [32]. Women who have 2 to 5 drinks a day are 1.5 times more likely to 
develop breast cancer than non-drinkers [33]. This association may be modified by hormone 
receptor expression: ethanol and acetaldehyde interfere with estrogen pathways and may trigger 
the expression of hormone receptors (e.g., estrogen) in breast tumors [34, 35].  However, other 
mechanisms have also been proposed; alcohol consumption is associated with genetic 
polymorphisms, such as increased reactive oxygen species through induction of CYP2E1 [36], 
enhanced mammary gland susceptibility to carcinogenesis, and increased mammary carcinogen 
DNA damage [37]. 
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Bodyweight 
Overweight and obesity, as measured by high body mass index (BMI), moderately 
increases the risk of breast cancer in postmenopausal women.  However obesity is negatively 
associated with pre-menopausal breast cancer risk [38, 39].The increase in breast cancer risk 
with increasing BMI among post-menopausal women is largely the result of the associated 
increase in estrogens [40]. A meta-analysis of 13 studies of post-menopausal women reported 
that circulating concentrations of sex hormones (e.g., estrogens) were higher in obese women 
than in women with lower BMI [41].  Higher BMI usually means increased adipose tissue which 
produces aromatase, an enzyme responsible for a key step in biosynthesis of estrogens [42]. This 
increased total aromatase activity along with high estrogen levels may explain the increased risk 
of breast cancer among obese post-menopausal women compared to non-obese post-menopausal 
women [23, 40, 41, 43].  However, obesity also has effects on many different biological 
processes, including systemic and local inflammation [44], so mechanisms of obesity are 
complex. 
Geographic Location 
In the United States breast cancer rates vary by geographic region. Geographic variation 
is based on a number of factors including demographics, lifestyle, regional cultures, and access 
to screening and care [16]. The Centers for Disease Control and Prevention (CDC) reported that 
the highest incidence rates of breast cancer were in the Northeast followed by the Midwest [45]. 
These areas are also where the 2015 Annual Report to the Nation on the Status of Cancer 
reported the highest rates of luminal breast cancers. Authors noted that these areas tend to also 
have higher mammography screening rates [16]. Rates of triple negative breast cancers were 
higher in the Southeast; these rates increased with increased percentage of non-Hispanic black 
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women [16]. Death rates from breast cancer are highest in the South, followed by the Midwest, 
Northeast and West [45].  
1.1.3. Non-established Non-Genetic Risk Factors 
Tobacco Smoke 
The relationship between cigarette smoking and breast cancer risk is unclear. Despite 
extensive research on smoking and breast cancer there is no scientific consensus, partly because 
of concern that the association may be confounded by alcohol consumption [46] and because 
studies have not consistently shown an increase in risk with duration or intensity of smoking 
[47]. Some studies suggest current smoking to be linked to increased risk of breast cancer 
through DNA damage mechanisms [48].  However there is also evidence that smoking may 
decrease ovarian function and therefore endogenous exposure to estrogen, with a resulting 
protective effect on breast cancer [49]. A meta-analysis of cohort studies and an original cohort 
analysis on active smoking and breast cancer risk reported increased risk among current smokers, 
especially when smoking begins at an early age [50]. Data from the Nurses’ Health Study 
suggests that active smoking, especially before the age of 20 or before first birth, may be 
associated with a modest increase in breast cancer risk. The risk increase for current smokers and 
former compared to never-smokers was approximately 12% and 9%, respectively [51]. Data 
from the Women’s Health Initiative reported evidence of an association between active and 
passive smoking and breast cancer risk among postmenopausal women [52]. 
1.2. Environmental Exposures and Breast Cancer 
Breast cancer is a very complex disease because both genetic and environmental factors 
contribute to its etiology [53]. Environmental exposures, defined in this proposal as 
environmental pollutants and chemicals, are a potential cause of breast cancer [54]. Over the past 
few decades, a number of environmental pollutants have been considered, however 
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epidemiologic studies have reported inconsistent or null results [55-57]. Organochlorines are a 
diverse group of synthetic chemicals that have been widely studied. This group of chemicals 
includes polychlorinated biphenyls (PCBs), dioxins, and organochlorine pesticides such as 
dichlorodiphenyl-trichloroethane (DDT), lindane, and hexachlorobenzene. Though use of DDT 
and PCBs has been banned in the United States since the 1970s, some organochlorine 
compounds have continued to accumulate and persist in the environment and have been 
measured in human tissues.  Laboratory research provides evidence that a number of persistent 
organochlorine compounds (e.g., PCBs and DDT) exhibit varying estrogenic and anti-estrogenic 
activity in biological assays [58]. These compounds can affect the body’s estrogen production 
and metabolism and may contribute to breast cancer risk by damaging DNA, disrupting 
hormones, promoting tumor growth, or increasing susceptibility by altering mammary gland 
development [59-61]. The majority of epidemiologic studies studying these chemicals have 
reported null associations [62], including large prospective cohort studies [63-65], a large case-
control study [66] and a meta-analysis of 22 epidemiologic studies [56]. It has been suggested 
that the null association between organochlorine compounds and breast cancer may reflect a true 
lack of association or to shared methodological weakness across a large number of studies [67].  
In contrast to environmental chemicals, which have typically shown weak or inconsistent 
associations, environmental ionizing radiation has been strongly linked to breast cancer [68]. 
Evidence of this comes from studies of women in Hiroshima and Nagasaki when the United 
States dropped the atomic bombs and women exposed to massive amounts of radiation from the 
1986 Chernobyl nuclear reactor accident [69, 70]. The association is not as clear with radiation 
exposures experienced by the general public or people living in areas that have higher radiation 
levels (e.g., near industrial accidents or nuclear activities) [71]. Other possible risk factors, such 
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as occupational exposures, electromagnetic fields, light at night, solar radiation, and some 
environmental chemicals have been indicated by some studies, but the results have been 
inconclusive [55, 61, 72, 73].  
1.3. Methodological Issues 
Examining environmental exposures and breast cancer risk in the general population is 
challenging given a number of methodological issues: exposures are often poorly quantified; it is 
difficult to find an unexposed group because many environmental contaminants are ubiquitous in 
the environment; the range of measured exposures may be narrow (with few or no unexposed or 
highly exposed); small hypothesized relative risks require very large studies for sufficient 
statistical power; and the timing of measurement may not be etiologically relevant [67, 71]. 
Exposure measurements made near the time of diagnosis or interview may not represent the 
appropriate empirical induction period between exposure and development of breast cancer. 
Latency periods of 8 to 15 years have been reported for breast cancer [67, 74-76]. Therefore, if 
an environmental exposure were related to breast cancer, empirical induction periods could be at 
least one to two decades [67]. Another common concern regarding exposure measurement comes 
from self-report observational studies. Self-reported exposures are subject to multiple sources of 
error (e.g., recall bias) resulting in misclassification. If the resulting misclassification is non-
differential, a small, real effect may not be detected.  Therefore another challenge is having a 
large enough study to have sufficient statistical power [67, 71]. 
Ideal environmental exposure assessment would provide information about the agent, 
dose, exposure pathway, timing in relation to the empirical induction period, tumor growth rate, 
and an unexposed comparison population [67]. However, gathering this kind of detailed data is 
expensive, time consuming and sometimes not practical. It is also true that low-level 
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environmental exposures are also often associated with small hypothesized relative risks that are 
difficult to assess statistically in small studies. With the exception of major releases of 
contaminants due to an industrial accidents or atomic bomb, environmental exposure is 
challenging to study in the general population [71].  
1.4. Personal Care Product Sources and Exposure 
The average American woman uses 12 personal care products a day, resulting in daily 
exposure to an estimated 126 unique chemicals [77]. Because certain chemicals in personal care 
products are suspected endocrine disrupters (e.g., phthalates, parabens, triclosan) [78, 79], there 
is concern that exposure to personal care products may be associated with risk of breast cancer 
and/or may have adverse reproductive health effects. In vitro and animal studies have 
demonstrated that endocrine disrupting chemicals can mimic estrogens [73], alter hormonal 
signaling, affect developing reproductive systems [80], and/or disrupt normal mammary 
development [81]. However, there is currently no definitive evidence for the same effects in 
humans [82-85].  
The strongest evidence to support concern for endocrine disrupting chemicals comes 
from experimental animal studies [85]. However, laboratory animals are usually exposed to 
individual chemicals over short periods of time (often at higher doses than humans) whereas 
humans are typically exposed to multiple endocrine disrupting compounds simultaneously over 
many years. Consequently, there is concern that laboratory animal data have not addressed the 
patterns of exposure to these complex mixtures which may be most relevant [86, 87]. At the 
same time, more information is needed to characterize the nature of human exposure in order to 
design more appropriate animal and in vitro studies of complex mixtures as well as validate 
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computational models of predicted exposure. To address the limitations in experimental animal 
studies and capture the exposure characteristics in human populations, human studies are needed.   
Some key challenges have impeded progress in understanding the relationship between 
personal care product use and health outcomes in humans.  First, publically available data on 
personal care product usage patterns in the United States typically lack large sample populations 
or include only specific types of product users [88, 89 , 90, 91]. Currently the only population-
based studies of personal care product use that have a comparison group of infrequent personal 
care product users are limited to other countries [92, 93], or small populations within the United 
States [94]. Second, studies that have collected data on product use have described correlations 
between use patterns for only a limited numbers of products. Third, studies to date have not 
placed the personal care product exposures in context of other exposures, particularly those in 
relevant biological pathways.  
1.5. Data Collection in Epidemiological Studies 
Wu et al [94] used a telephone interview to collect information on the frequency of use of 
~30 types of personal care products from 604 Californian participants. Participants were 
recruited in three age groups: children, their parents, and adults age 55 years or older. Manová et 
al [93] used a postal questionnaire survey to examine patterns of personal care product use in 
three Western European countries: Switzerland, Germany, and the Netherlands. A self-
administered questionnaire asked participants to recall their use of eight personal care product 
categories (face cream, body lotion, aftershave, hand cream, makeup foundation, lipstick, lip 
care, and sunscreen) over the past year. The third study used a digital questionnaire to collect 
information on the use of 32 different personal care products among 516 men and women living 
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in the Netherlands [92]. In the sections that follow, the main findings from these three studies are 
summarized. 
Prevalence 
Lotion/cream products had the overall highest prevalence of use. Manová et al [93] 
reported that among adult females the prevalence of use was highest for face lotion (95.9%) and 
hand lotion (95.3%). Biesterbos et al [92] reported that a high percentage of respondents (70-
95%) used a combination of two skin care products (e.g., day cream and night cream). A 
majority of users (>50%) indicated that they used deodorant, day cream, night cream, make-up 
remover, mascara, eye pencil and eye brow pencil once a day [92].  The California study [94] 
found that the different hygiene products (e.g., body lotion and hand lotion, shampoo and 
conditioner) were strongly correlated with each other. The use of different skincare products 
were moderately correlated with each other and the use of some cosmetics were correlated (e.g., 
foundation and mascara were correlated). Foundation and mascara were also correlated with hair 
styling and face cleaning products [94]. In all three studies personal care product use patterns 
varied by socio-demographic factors including age, race, education [92-94] and by climatic 
region in the California study (e.g., northern vs. southern California) [94].  
Age/Region 
Younger female adults in northern California had a higher prevalence of a wider range of 
personal care product use than older female adults in central California [94]. Younger females 
had higher use frequencies of shampoo, conditioner and hair mousse compared to older female 
adults. The older female adults reported a higher prevalence of hair spray, permanent hair 
treatment, ear and nasal care products, foundation, mascara, nail polish and hair dye [94]. In 
Europe, younger adults were heavier users of personal care products such as foundation, lip care, 
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and sunscreen [93]. Female participants in the oldest age group, 66 years and older, had the 
highest prevalence of lipstick use (72.6%).  
Race/Ethnicity 
According to a study in California [94] race/ethnicity was an important factor among 
younger women in determining personal care products use. Compared to younger non-Hispanic 
white women, younger African American women were more likely to have their hair treated 
permanently (including chemical straightening or relaxing). However this study was based on a 
very small number of African American women (N=10) compared to non-Hispanic white women 
(N=206) so comparison may be subject to small sample biases [94]. An analysis of 2,540 
samples collected from participants of the National Health and Nutrition Examination Survey 
1999-2000 found that African American women had higher urinary levels of  monoethyl 
phthalate, a phthalate found in personal care products, compared to non-Hispanic white 
women[84]. The authors speculated that these differences are likely due to differences in hair 
texture and cultural practices [94].   
The European studies did not specify race/ethnicity, however participants from 
Netherlands, Switzerland, and Germany were categorized by self-reported skin type: very fair, 
fair, light brown, medium brown, dark brown, and black [93]. The prevalence of use of face 
cream, body lotion, hand cream, makeup foundation, lipstick, lip care, and sunscreen was higher 
among those with very fair, fair, and light brown skin compared to those with medium brown, 
dark brown, and black skin [93]. This study did not look at hair products, an important category 
when considering race/ethnicity because African American women are more likely to use hair 
products that contain endocrine disrupting compounds [95, 96]. 
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Education 
In the US, educational attainment influenced choices of products, particularly for 
products where awareness of a healthy lifestyle could be considered a factor (e.g., more frequent 
use of sunscreen) or where higher income might play a role (e.g., more use of professional 
services for nails) [94]. Manová et al [93] reported that education had an influence on the 
prevalence of use of body lotion, hand cream, makeup foundation, lipstick, and sunscreen. The 
prevalence of use of body lotion and hand cream decreased as education increased and the 
prevalence of sunscreen use increased as education increased. The largest proportion of 
sunscreen users were university graduates (92.4%). For cosmetics (i.e., makeup foundation and 
lipstick) the prevalence of use was highest among the participants who completed the European 
equivalent of high-school [93].  
Patterns of Co-use 
Manová et al [93] reported that most (64.8%) adult females reported using two or more 
personal care products concurrently and regularly.  The most common combination of products 
that adult females used was sunscreen, face cream, and body lotion. A similar pattern was 
reported in the U.S. Wu et al. [94] found moderately positive correlations between the use of 
face moisturizer and body lotion among California residents. In the Netherlands, Biesterbos et 
al.[92] also reported co-use of products. Most products within the hair care, skin care, or 
cosmetic product groups were correlated. Day cream was often used by the same people who 
used night cream (kappa=0.49) and the use of powder was likely among people who used 
foundation (kappa=0.67). Among those who applied nail polish, 93% also used nail polish 
remover (kappa=0.95), 82.5% of all users who applied eye shadow also used mascara 
(kappa=0.62). Surprisingly, not all products that seem to be associated were used simultaneously. 
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For example, out of 499 respondents who use shampoo, only 173 used conditioner as well 
(kappa=0.03) [92].  
Currently, there are no studies that have examined a large, diverse sample population to 
evaluate exposure patterns for a wide range of personal care products. In addition, the previous 
studies used Cohen’s Kappa coefficients and Spearman correlation coefficient to describe 
patterns of co-use. To advance public health knowledge about the health effects of personal care 
product use, there is a need to more comprehensively describe patterns of use. 
1.6. Personal Care Products and Breast Cancer 
There is concern that use of personal care products may be associated with breast cancer 
risk [67]. It has been hypothesized that chemicals in personal care products (e.g., parabens and 
phthalates) may act as endocrine disrupting chemicals (EDCs) [79, 97] possibly mimicking the 
effects of carcinogenic effects of estrogenic exposures [98, 99].  In vitro and animal studies have 
demonstrated that these chemicals can mimic estrogens [73], alter hormonal signaling, affect 
developing reproductive systems [80], and/or disrupt normal mammary development [81]. 
However, there is currently no definitive evidence for the same effects in humans [82-85]. There 
have been studies showing associations between personal care product use and increased 
phthalate or paraben exposure. A cross-sectional analysis of controls from a population based 
case-control study of women in northern Mexico reported increasing numbers of personal care 
products used were associated with higher urinary concentrations of monoethyl phthalate (MEP), 
a phthalate that is commonly used in certain personal care products [100]. The Environmental 
and Reproductive Health [EARTH] Study, a cohort study of women ages 18 to 45 years, showed 
evidence of a monotonic dose-response relationship between total number of products used and 
urinary paraben and phthalate metabolite concentrations [101].  
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Very few studies have evaluated risk of breast cancer in association with components of 
personal care products or individual products and those studies have not strongly supported 
increasing risk of breast cancer in association with personal care product use in humans [102]. A 
possible relationship between phthalate exposure and breast cancer has been investigated in 
several studies but has yielded mixed results. A population based case-control study of women 
residing in northern Mexico, with 233 histopathologically confirmed breast cancer cases and 221 
age-matched controls studied exposure to several phthalates found in a wide range of personal 
care products. This study reported that urinary concentrations of monobenzyl phthalate (MBzP) 
and mono (3-carboxypropyl) phthalate (MCPP)) were negatively associated with breast cancer 
(MBzP: OR= 0.46, 95% CI: 0.27–0.79; MCPP: OR= 0.44, 95% CI:0.24–0.80).   However, MEP 
and mono-2-ethyl-5-carboxypentyl phthalate (MECPP), a metabolite of DEHP, were 
significantly associated with increased breast cancer risk (MEP: OR =2.20, 95% CI: 1.33–3.63; 
MECPP: OR=1.68, 95% CI: 1.01–2.78) [102]. The odds ratio for MECPP was weak and 
borderline significant and other metabolites of DEHP were not significantly different between 
cases and controls [102]. 
Epidemiologic research related to personal care products has mostly emphasized specific 
component ingredients in deodorants/ antiperspirants and hair dye. It has been suggested that 
aluminum compounds and other ingredients (e.g., parabens) in deodorant and antiperspirant 
could be related to breast cancer because they have estrogen-like effects [103] and are applied 
frequently to an area near the breast [103, 104]. However, epidemiological studies of the 
relationship between deodorants/antiperspirants and breast cancer have reported conflicting or 
inconclusive results [88-90].  A 2002 population-based case-control study of 813 women 
diagnosed with breast cancer and 793 controls reported no increased risk for women who 
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reported using underarm deodorant or antiperspirant [89].  A 2003 retrospective case-only study 
of 437 females diagnosed with breast cancer reported that age of breast cancer diagnosis was 
significantly earlier in women who used deodorant/antiperspirant more frequently [90]. In 2006, 
a study of hospital patients in Iraq compared 54 women with breast cancer and 50 women 
without breast cancer; they reported no association between antiperspirant use and the risk of 
breast cancer [88].   
Personal use of hair dye and breast cancer risk has been widely studied. Meta-analyses of 
hair dye products conclude that there is no consistent evidence for these products increasing 
breast cancer risk [91, 105]. A meta-analysis of 12 case-control studies and 2 cohort studies 
published between 1977 and 2002 that examined the association between hair dye and breast 
cancer concluded that use of hair dyes does not increase breast cancer risk in women [91]. 
However, some sub-populations with more exposure may be at increased risk [106]. A 2009 
meta-analysis reported that compared to other occupations, hairdressers and salon workers have 
a slightly increased risk of breast cancer [106].  
1.7. Conclusions 
This project seeks to describe personal care product use patterns among women in the 
United States and to estimate the associations between product use patterns and breast cancer 
risk. Exposure to personal care products is common in the general U.S. population, however 
measuring this exposure is complex. Currently, to the best of our knowledge, there are no other 
studies that have evaluated personal care product use patterns among a large, diverse sample 
population. Personal care product exposure is difficult to characterize because each product is a 
complex mixture and multiple products are often used in combination by one person.  Also, 
many individual product exposures are correlated, making it difficult to measure the health 
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effects of any single exposure. To better characterize patterns of personal care product use and 
the risk associated with usage, this project will use detailed personal care product use 
information, together with latent class analysis (LCA), to create latent classes that describe 
exposure to broad patterns of personal care product use. LCA can be used to address these 
limitations by identifying latent classes which describe variability among multiple, correlated, 
and observed variables [107 714].  
After identifying classes of personal care product use, this project will identify how these 
classes are related to other important breast cancer risk factors and to breast cancer risk. If 
patterns of personal care product use are associated with breast cancer or breast cancer risk 
factors, results from this study may help inform prevention strategies.  
 
18 
 
CHAPTER 2: METHODS 
2.1. Specific Aims and Hypotheses 
Specific Aim 1. Objective: Identify groups of personal care product users among United 
States women and describe the prevalence of these product use subgroups within strata defined 
by race/ethnicity. Hypothesis: There are latent classes of personal care product use that vary 
according to race/ethnicity. Approach: Using data from the NIEHS Sister Study’s Personal Care 
Questionnaire, latent class analysis (LCA), a data reduction tool, will be used to identify classes 
of personal care product users based on broad patterns of exposure. Latent classes will be 
constructed for three product categories: (1) beauty products, (2) hair products, and (3) skincare 
products. Characteristics of participants will be described by race/ethnicity.  
Specific Aim 2. Objective: Estimate the association between personal care product 
latent class membership and breast cancer risk factors. Hypothesis: Personal care product 
varies according to known and suspected breast cancer risk factors. Approach: Stratified 
logistic regression will be used to estimate prevalence differences (PDs) and 95% confidence 
intervals (CIs) to examine the association between personal care product latent class (Aim 1) 
and breast cancer risk factors among women in the Sister Study. These risk factors include 
age, age at menarche, parity, age at first pregnancy, duration of breastfeeding, OC or HRT 
use, adult BMI, smoking, alcohol use, geographic region, education, and family history.   
Specific Aim 3. Objective: Estimate the associations between personal care product 
use classes and breast cancer risk within strata defined by race, controlling for appropriate 
confounders.  Hypothesis: Personal care product latent classes will be associated with breast 
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cancer risk in multivariable models. Approach: We will use Cox proportional hazards 
regression to estimate breast cancer risk in association with personal care product latent 
classes defined in Aim 1, adjusting for confounders and stratifying by race/ethnicity. 
2.2. Study Design 
2.2.1. NIEHS Sister Study 
The Sister Study is a large prospective cohort study directed at identifying environmental 
and genetic risk factors for breast cancer. The study consists of 50,884 women who had at least 
one sister diagnosed with breast cancer but were cancer-free themselves at time of enrollment. 
Study enrollment began in 2003 and ended in 2009; eligible women were 35-74 years of age. 
Participants were recruited nationally through health professionals, breast cancer advocates, the 
Internet, trained recruitment volunteers, and a national advertising campaign. Baseline 
enrollment activities included a computer-assisted telephone interview and self-administered 
questionnaires that collected information about environmental and genetic risk factors for breast 
cancer. The Sister Study was approved by the institutional review boards at the National Institute 
of Environmental Health Sciences and Copernicus Group. Written informed consent was 
provided by study participants. The present analysis was limited to non-Hispanic white 
(n=42,558, 84% of participants) and non-Hispanic black (n=4,462, 9% of participants) women; 
there were too few Hispanic (5%) and Other (3%) participants to include in this analysis. 
2.2.2. Data acquisition 
 Permission to use the data was obtained from the Principal Investigator of the Sister 
Study, Dr. Dale P. Sandler, at the National Institutes of Environmental Health Sciences in 
Research Triangle Park, North Carolina. IRB approval was obtained from the UNC IRB for 
analyzing the data. 
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2.3. Data Analysis 
2.3.1. Exposure assessment and categorization 
 Detailed self-reported use of 48 personal care products was collected during the 
baseline phase of the study (Table A.4). Frequency of use (5-level-response option) during the 
previous 12 months was reported.  Because performing LCA of such a large data matrix 
(almost 50,000 participants, with 48 questions per participant and 5 response categories per 
question) is too computationally challenging for the SAS program PROC LCA, we employed 
a variety of data reduction steps. First, using histograms to examine the distribution of 
exposure responses, we condensed the number of response categories from five into three 
(Table A.5). Second, we separated the different product types into three different product 
categories and separate latent classes were constructed for each category: (1) beauty products, 
(2) hair products, and (3) skincare products (Table A.5). Finally, to further reduce 
dimensionality, and improve interpretability of the model we used a method based on Dean et 
al. [108] to select the variables that were most useful for distinguishing among latent classes 
(i.e., ≥10% difference in posterior probabilities between classes) (Table A.5). Variables that 
were determined not to contribute to the distinction between latent classes were removed from 
the model. Within each product category, latent classes were described and considered as 
exposure variables (Table 3.1). 
2.3.2. Breast cancer assessment  
Participants reported breast cancer diagnoses on annual and biennial health 
questionnaires, or by calling the Sister Study helpline. Women who reported an incident breast 
cancer during follow-up were asked to authorize release of pertinent medical records. Response 
rates were >94% over follow-up [109].  Among participants in our sample population, 2,328 
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breast cancers were reported during 299,689 person-years (average follow-up ~5.4 years). By the 
time of the present analysis, pathology reports or medical records had been obtained for >80% of 
these cases (n=1,923).  Confirmation of self-reported breast cancer diagnoses by medical record 
was very high [positive predictive value (PPV)=99.5%] [110]. After medical record review, self-
reported ER status information was confirmed for 99% of ER positive cases, and 85% of ER 
negative cases.  Therefore, we used self-reported tumor.  
2.3.3. Effect modification 
All models were stratified by race. Race/ethnicity was based on self-report at baseline. 
The two race/ethnicities included in this analysis were non-Hispanic white and non-Hispanic 
black women. In analyses investigating associations by menopausal status at the time of breast 
cancer diagnosis, women who became postmenopausal during the follow-up period were 
censored at the time of menopause and the person-time that accumulated after menopause 
contributed to postmenopausal person-time at risk. Menopausal status was self-reported by the 
participant at enrollment and during follow-up.  Women who reported that they had undergone 
natural menopause, hysterectomy, bilateral oophorectomy, irradiation to the ovaries, or otherwise 
reported cessation of menstruation were classified as post-menopausal; women who reported that 
they were still cycling were classified as pre-menopausal. Women who did not know if they had 
undergone menopause (N=16) or had never had their period (N=4) were excluded. In sensitivity 
analyses among post-menopausal white women only, models were stratified by ER status (ER 
positive or ER negative according to the clinical record), and breast cancer type (in situ or 
invasive). 
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2.3.4. Confounding 
 To identify possible confounders, we considered the association between latent classes 
and breast cancer risk factors (Table 2.1). The following covariates, measured at baseline, were 
included in adjusted models: menopausal status (pre-menopausal or post-menopausal), education 
(< high school or ≥high school), age at first birth (nulliparous, <26 years, or ≤26 years), parity 
(nulliparous, 1-2 children, or ≥3 children) , duration of breastfeeding (<12 months or ≥12 
months), oral contraceptive (OC) use (ever or never), post-menopausal hormone therapy (HT) 
use among women >50 years (ever or never), alcohol consumption (never drinker, former 
drinker, currently drink <1 drink/day or currently drink ≥1 drink/day), adult body mass index 
(BMI) (<25kg/m2, 25 to <30kg/m2, or ≥30 kg/m2), family history (having one sister with breast 
cancer or ≥1 sister and/or a mother with breast cancer), smoking status (never smoker, past 
smoker, current smoker), and age at menarche (<12 years or ≥12 years), and region (West, 
South, North, East). In sensitivity analyses, models were stratified by ER status and breast cancer 
subtype. More details on measurement and definition of potential confounders are listed in Table 
2.1. 
2.3.5. Statistical methods 
Latent classes 
 LCA was used to identify groups of individuals with similar patterns of personal care 
product use.  LCA is a data reduction tool that describes variability among multiple, correlated, 
observed variables in terms of a fewer number of unobserved variables called latent classes. It 
has been used for identifying patterns of exposure when the exposure is a complex combination 
of separate factors [107]. Personal care products were categorized into three product categories 
and separate latent classes were constructed for each category: (1) beauty products, (2) hair 
products, and (3) skincare products.  
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For each product category we fit a sequence of LCA models starting with two classes and 
increasing the number of classes for each model (up to six). To identify an optimal but minimal 
number of classes, Akaike’s information criterion (AIC), the Bayesian information criterion 
(BIC), and entropy were considered [107]. A smaller AIC and BIC and higher entropy for a 
particular model suggests a better model fit [107]. A summary of the fit statistics and entropy are 
shown in Table 3.1. The classes were described and labeled based on item-response probabilities 
[108] and ability to identify which variables were driving each class [107]. 
To assign participants class membership, we used a common classify-analyze approach 
referred to as the maximum-probability assignment rule, where individuals are assigned to the 
class in which they have the highest posterior probability of membership [111].  Item-response 
probabilities provided the basis on which each latent class was interpreted [112]. The correlation 
among use patterns for the three product types was evaluated by Spearman correlation 
coefficients of the item response variables’ posterior probabilities. 
Association between latent classes and potential confounders 
Logistic regression stratified by race was used to estimate age-adjusted prevalence 
differences and 95% confidence intervals for potential confounders and latent class membership 
for the three different product categories (Table A.6). Covariates that were considered as 
potential confounders are listed in Table 2.1. 
Association between latent classes and breast cancer risk 
Multivariable Cox proportional hazards models were used to estimate hazard ratios (HRs) 
and 95% confidence intervals (95% CIs) for the association between the personal care product 
latent classes and breast cancer risk. Statistical models used age as the time scale, where 
participants entered the analysis at their baseline age (left-truncation) and exited at their 
event/censoring age; person-time was accrued from enrollment. Follow-up extended until breast 
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cancer diagnosis (event) or the date of last follow-up (censored). All models were stratified by 
race and adjusted for potential confounders. 
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Table 2.1. Measurement and definition of potential confounders 
Variables Measurement Code in statistical analysis 
Age at baseline Self-administered form 5 year age categories 
Age at menarche Self-administered form <12 years or ≥12 years 
Menopausal statusa Self-administered form Pre-menopausal or post-
menopausal 
Education Self-administered form < high school or ≥high school 
Age at first live birth Self-administered form Nulliparous, <26 years, or ≤26 
years 
Parity Self-administered form Nulliparous, 1-2 children, or ≥3 
children 
Duration of breastfeeding Self-administered form <12 months or ≥12 months 
Oral contraceptive use Self-administered form Ever or never 
Post-menopausal hormone 
therapy use 
Self-administered form Ever or never (among women 
>50 years) 
Alcohol consumption Self-administered form Never drinker, former drinker, 
currently drink <1 drink/day or 
currently drink ≥1 drink/day 
Adult body mass index Examiner form  <25kg/m2, 25 to <30kg/m2, or 
≥30 kg/m2 
Family history Self-administered forms Having one sister with breast 
cancer or ≥1 sister and/or a 
mother with breast cancer 
Smoking status Self-administered forms Never smoker, past smoker, 
current smoker 
Geographic location Self-administered forms West, Midwest, Northeast, and 
South 
aThe definition of menopause was described in 2.2.4. 
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CHAPTER 3: ASSOCIATIONS AMONG PERSONAL CARE PRODUCT USE 
PATTERNS AND EXOGENOUS HORMONE USE IN THE SISTER STUDY 
 
3.1. Overview 
Background: It is hypothesized that certain chemicals in personal care products may alter risk of 
adverse health outcomes. The primary aim of this study was to use a data-centered approach to 
classify complex patterns of exposure to personal care products and to understand how these 
patterns vary according to use of exogenous hormone exposures, oral contraceptives (OCs) and 
postmenopausal hormone therapy (HT).  
Methods: The NIEHS Sister Study is a prospective cohort study of 50,884 U.S. women. 
Limiting the sample to non-Hispanic blacks and whites (N=47,019), latent class analysis (LCA) 
was used to identify groups of individuals with similar patterns of personal care product use 
based on responses to survey questions. Personal care products were categorized into three 
product types (beauty, hair, and skincare products) and separate latent classes were constructed 
for each type. Adjusted prevalence differences (PD) were calculated to estimate the association 
between exogenous hormone use, as measured by ever/never OC or HT use, and patterns of 
personal care product use. 
Results: Latent class analysis (LCA) was used to reduce data dimensionality across 48 
individual personal care product use questions and to identify groups of individuals with similar 
patterns of personal care product use. Three latent classes were identified for both the beauty and 
hair product groups; the skincare product group had four classes. There were strong differences 
in latent class distribution by race, particularly for hair care products. For both blacks and whites, 
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exogenous hormone exposures were associated with higher levels of product use, especially 
beauty and skincare products. 
Discussion: Relative to individual product use questions, latent class variables capture complex 
patterns of personal care product usage. These patterns differed by race and were associated with 
ever OC and HT use. Future studies should consider personal care product exposures with other 
exogenous exposures when modeling health risks. 
3.2. Introduction 
The average American woman uses 12 personal care products a day, resulting in daily 
exposure to an estimated 126 unique chemicals [77]. Because certain chemicals in personal care 
products are suspected endocrine disrupters (e.g., phthalates, parabens, triclosan) [78, 79], there 
is concern that exposure to personal care products may be associated with risk of breast cancer 
and/or may have adverse reproductive health effects. In vitro and animal studies have 
demonstrated that endocrine disrupting chemicals can mimic estrogens [73], alter hormonal 
signaling, affect developing reproductive systems [80], and/or disrupt normal mammary 
development [81]. However, there is currently no definitive evidence for the same effects in 
humans [82-85].  
The strongest evidence to support concern for endocrine disrupting chemicals comes 
from experimental animal studies [85]. However, laboratory animals are usually exposed to 
individual chemicals over short periods of time (often at higher doses than humans) whereas 
humans are typically exposed to multiple endocrine disrupting compounds simultaneously over 
many years. Consequently, there is concern that laboratory animal data have not addressed the 
patterns of exposure to these complex mixtures which may be most relevant [86, 87]. At the 
same time, more information is needed to characterize the nature of human exposure in order to 
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design more appropriate animal and in vitro studies of complex mixtures as well as validate 
computational models of predicted exposure. To address the limitations in experimental animal 
studies and capture the exposure characteristics in human populations, human studies are needed.   
The objective of the current study was to use data from 47,019 women in the NIEHS 
Sister Study to characterize patterns of personal care product use across a wide range of 
products.  We hypothesized that individuals would be classifiable according to broad patterns of 
personal care product usage, with patterns differing by race. We also hypothesized that personal 
care product use would be correlated with other exposures, notably other exogenous estrogens 
(e.g., OC and HT use) potentially associated with disease risk. To test these hypotheses, we used 
latent class analysis (LCA) to identify groups of women by patterns of product use and compared 
these patterns with in terms of past exogenous estrogen use. 
3.3. Methods 
3.3.1. Study population  
The Sister Study is a large prospective cohort study directed at identifying environmental 
and genetic risk factors for breast cancer. The study consists of 50,884 women who had at least 
one sister diagnosed with breast cancer but were cancer-free themselves at time of enrollment. 
Study enrollment began in 2003 and ended in 2009, and eligible women were 35-74 years of age. 
Baseline enrollment activities included a computer-assisted telephone interview and self-
administered questionnaires that elicited information about environmental and genetic risk 
factors for breast cancer. The Sister Study was approved by the institutional review boards at the 
National Institute of Environmental Health Sciences and Copernicus Group. Written informed 
consent was provided by study participants. The present analysis was limited to non-Hispanic 
white (n=42,558, 84% of participants) and non-Hispanic black (n=4,462, 9% of participants) 
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women (Table 3.1); there were too few Hispanic (5%) and Other (3%) participants to include in 
this analysis.  
3.3.2. Personal care product assessment 
Detailed self-reported use of 48 personal care products (Table A.4) was collected during 
the baseline phase of the study by inquiring about frequency of use (5-level-response options) 
during the previous 12 months. The five response options varied according to intended use of the 
product. For example, the response options for a product intended to be used regularly (e.g., hand 
lotion) included: (1) did not use, (2) used less than once a month, (3) used 1-3 times per month, 
(4) 1-5 times per week, (5) more than 5 times per week. Response options for products that are 
used less often (e.g., hair dye) included : (1) did not use, (2) 1-2 times a year, (3) every 3-4 
months, (4) every 5-8 weeks, (5) once a month or more.  To identify latent classes of personal 
care product use, each of three product categories were analyzed separately to identify latent 
classes for each category: (1) beauty products (e.g., lipstick, mascara, nail polish), (2) hair 
products (e.g., hair spray, hair relaxers), and (3) skincare products (e.g. facial lotion, hand 
lotion). 
3.3.3. Latent classes 
 LCA was used to identify groups of individuals with similar patterns of personal care 
product use.  LCA is a data reduction tool that describes variability among multiple, correlated, 
observed variables in terms of a fewer number of unobserved variables called latent classes. It 
has been used for identifying patterns of exposure when the exposure is a complex combination 
of separate factors [107]. Personal care products were categorized into three product categories 
[94], and separate latent classes were constructed for each category: (1) beauty products, (2) hair 
products, and (3) skincare products. To reduce dimensionality, improve interpretability of the 
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model, and improve classification and precision we used a method based on Dean et al. [108] to 
select the variables that were most useful for distinguishing among latent classes (i.e., ≥10% 
difference in posterior probabilities between classes). Variables that were determined not to 
contribute to the distinction between latent classes were removed from the model. 
We fit a sequence of LCA models starting with two classes and increasing the number of 
classes for each model (up to six). To identify an optimal but minimal number of classes, 
Akaike’s information criterion (AIC), the Bayesian information criterion (BIC), and entropy 
were considered [107]. A smaller AIC and BIC and higher entropy for a particular model 
suggests a better model fit [107]. A summary of the fit statistics and entropy are shown in Table 
3.2. The classes were described and labeled based on item-response probabilities [108] and 
ability to identify which variables were driving each class [107].   
To assign participants class membership, we used a common classify-analyze approach 
referred to as the maximum-probability assignment rule, where individuals are assigned to the 
class in which they have the highest posterior probability of membership [111].  Item-response 
probabilities provided the basis on which each latent class was interpreted [112]. The correlation 
among use patterns for the three product categories was evaluated by Spearman correlation 
coefficients of the item response variables’ posterior probabilities. 
3.3.4. Statistical analysis describing association between personal product use and 
exogenous hormone use 
We examined associations between personal product use and OC use (ever, never) for the 
entire sample and the association between personal care product use and HT use (never/ever) 
among women >50 years. We used logistic regression stratified by race to estimate age-adjusted 
prevalence differences and 95% confidence intervals in exogenous hormone use associated with 
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latent class membership for the three different product types. We considered education as a 
covariate but did not include it in the final model because it did not substantially change the age-
adjusted associations. 
3.4. Results  
3.4.1. Latent class descriptions 
Based on fit statistics and parsimony (Table 3.2), three latent classes were identified as 
optimal for both the beauty and hair product groups; the skincare product group had four classes. 
Figure 3.1 indicates the specific personal care products and the item response probabilities for 
each product. Analysis of fourteen initial beauty product usage items resulted in three latent 
classes (infrequent users; moderate users; frequent users) with nine contributing product items: 
mascara, lipstick, foundation, nail polish, perfume, eye shadow, eye liner, blush, and makeup 
remover (Figure 3.1, Table 3.4).  Analysis of fifteen hair product usage items resulted in three 
latent classes (infrequent users of hair products other than shampoo/conditioner; users of pomade 
and hair straightener; Frequent users of hair spray/hair gel) with six contributing product items: 
pomade, hair straightener, conditioner, hair spray, hair gel, and shampoo. Finally, analysis of 
nineteen skincare product usage items resulted in four latent classes (infrequent users; moderate 
users; frequent users; talcum powder users) with nine contributing product items: cleansing 
cream, anti-aging cream, body lotion, hand lotion, face cream, foot cream, petroleum jelly, 
talcum powder applied under arms, and talcum powder applied elsewhere. Short descriptions of 
the classes were created based on the item-response probabilities.    
3.4.2. Product use patterns by race 
Among non-Hispanic women in our study population, 91% were white and 9% were 
black (Table 3.3). Race was most strongly associated with differences in haircare product 
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classes; only 3% of white women were in the “users of pomade and hair straightener” group, 
while over two-thirds (67%) of black women were. There were also some differences in beauty 
product classes: white women were more frequent users than black women. The frequent lotion 
user category was the most common skin care class among both black and white women users 
(Table 3.3). Because of racial differences in population distribution across product classes, we 
report results separately by race in the subsequent analyses.  
3.4.3. Patterns of class membership across product categories (beauty, hair, skin) 
After considering the three different categories of personal care products in separate 
classification schemas, we also evaluated whether product usage class in one category (e.g. hair 
products) predicted use in another category (e.g. beauty products).  As shown in Figure 3.2, the 
product categories for whites tended to be correlated, i.e., frequent users of one product category 
tended to be frequent users of the other product categories, but correlation coefficients were 
modest.  The highest correlation of posterior probabilities of class membership was between 
infrequent users of beauty and skincare products (r=0.45). The next strongest correlations were 
between frequent beauty product users and frequent users in both the hair (r=0.39) and skincare 
(r=0.34) categories. For black women the correlations among usage patterns for the different 
product categories were low except for skin and beauty (r=0.39).  
3.4.4. Exogenous hormonal exposures and product use  
The prevalence of OC use history was 85% for whites and 86% for blacks; the prevalence 
of HT among women over age 50 was 66% for whites and 48% for blacks.  Product use showed 
strong associations with exogenous hormonal exposures (Figure 3). White and black women who 
were “moderate” or “frequent” users of beauty products were more likely to have ever taken 
OCs. Among white women, compared to “infrequent” users of beauty products, the age-adjusted 
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differences in prevalence of ever using OCs for “moderate” users and “frequent” users was 7% 
and 8%, respectively. Among black women, compared to “infrequent users”, the age-adjusted 
prevalence differences of ever using OCs were 8% for “moderate” users and 10% for “frequent” 
users of beauty products. White women over age 50 who were “moderate” users and “talcum 
powder” users were more likely to have ever used HT compared to “infrequent” users of 
skincare products; the age-adjusted difference in prevalence of ever receiving HTs for 
“moderate” users and “talcum powder” users was 12% and 11%, respectively. Among black 
women, the age-adjusted difference in prevalence of ever using HTs for “moderate” users 
compared to “infrequent” users of skincare products was 10%.  
3.5. Discussion  
We found that use of LCA could identify a relatively small number of subgroups of 
women with distinct personal care product use and that personal care product use varied by race.  
We also showed that the women with the highest use of personal care products are more likely to 
have used the common exogenous hormone medications, OC or HT. Previous studies have 
examined correlation structure between specific personal care products [92-94], but such studies 
were not aimed at reducing the complexity of individual product usage patterns, nor did these 
studies evaluate associations between personal care product use and other exposures. 
Some key challenges have impeded progress in understanding the relationship between 
personal care product use and health outcomes in humans.  First, publically available data on 
personal care product usage patterns in the United States typically lack large sample populations 
or include only specific types of product users [88, 89 , 90, 91]. Currently the only population-
based studies of personal care product use that have a comparison group of infrequent personal 
care product users are limited to other countries [92, 93], or small populations within the United 
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States [94]. Second, studies that have collected data on product use have described correlations 
between use patterns for only a limited numbers of products. Third, studies to date have not 
placed the personal care product exposures in context of other exposures, particularly those in 
relevant biological pathways.  
Our analysis addresses some of these challenges.  First, we used a large, nationwide study 
of personal care product use and other environmental exposures to study patterns of exposure.  
Second, we took a broad approach to characterizing exposure, incorporating information on 24 
different personal care products included in the Sister Study’s personal care questionnaire.  
Finally, we used LCA to identify exposure patterns in the context of other, relevant exposures. 
However, with currently available data we cannot specify a commonality of chemical exposures, 
only a commonality of which products tend to be used together by different groups of women. 
Information about specific chemicals or ingredients in personal care products was not captured in 
the questionnaire. 
The use of LCA was a key strength of our analysis. As opposed to a variable centered-
approach that considers how variables are related to each other, LCA is a data-centered approach 
that considers how variables are grouped within individuals. LCA can reduce and organize large, 
multifaceted data sets and create manageable categorical data elements to summarize complex 
patterns [107]. LCA has been used to capture complex exposures in a variety of research 
settings. For example, it has been used to organize and describe subgroups of weight loss 
strategies and disordered eating among women [112] and to identify subgroups of emerging 
sexual behaviors among adolescents [113]. LCA has also been used to identify substance use 
behavior among adolescents to inform programs that could be targeted for or tailored to the 
different population subgroups that are expected to show the strongest response [114].   
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Our results were consistent with some previous studies.  We observed race-related 
patterns of hair product use similar to those observed in previous smaller studies [84, 95, 115, 
116]. The class that was characterized by use of pomade and hair straightener contained the 
majority of black women, but only 3% of white women. In a small study with ten black and 206 
white participants from California [94] African American women were more likely to have their 
hair treated permanently (including chemical straightening or relaxing). Although the National 
Health and Nutrition Examination Survey (NHANES) 1999-2000 did not collect questionnaire 
information on frequency of product use, a NHANES analysis of 2,540 participant samples 
found that compared to non-Hispanic white women, African American women had higher 
urinary levels of  monoethyl phthalate, a phthalate found in personal care products [84]. The 
authors of the NHANES suggest that these differences were likely due to differences in hair 
texture and cultural practices. While our analyses did not link product exposure with specific 
internal dose markers, future application of LCA approaches, or the patterns identified here, 
could be used to link specific exposure biomarkers with self-reported exposure information. 
To consider personal care product use in association with health outcomes, it is important 
to integrate these exposures with other biologically relevant and risk-related exposures. Having 
observed correlation within personal care product use classes (e.g. between heavy users of hair 
care products and heavy users of beauty products), we tested whether personal care product 
categories are associated with other relevant exposure patterns. OC and HT are examples of key 
exposures to exogenous estrogens. There were statistically significant associations between 
beauty and skincare product latent classes and OC and HT. Therefore, when personal care 
product use is being evaluated as a potential risk factor for hormonally-mediated conditions, we 
encourage researchers to consider possible confounding by OC and HT use. 
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Our analysis has several key strengths. LCA provides an objective method of 
distinguishing between groups of women on the basis of their patterns of personal care product 
use and, thus, potential chemical exposures.  The number of latent classes is determined, in part, 
by data-based metrics, and is small relative to the number of product use items.   The component 
product-use probabilities are complex and objectively discerning overall product-use data from 
casual inspection would be difficult. The NIEHS Sister Study provided a large dataset for this 
purpose.  
LCA provides an objective means of reducing data dimensionality; however, there are 
some limitations. For example, the classes can be difficult to interpret.  Labels were assigned to 
different classes based on our observation and interpretation of the probability based weights for 
class membership. Although there is some subjectivity in choosing the shorthand label 
descriptors for different classes, the precise item response probabilities are provided in 
supplemental tables (Tables A1-A3). Another limitation was that we could not consider them all 
of the personal care products together; due to the large number of variables we had to break LCA 
into three different product category models: beauty, hair and skin products. Also, the categories 
we identified with LCA may not be generalizable to other populations. Therefore it is important 
that these methods are replicated in other populations. Finally, our models only adjusted for age 
and not for other possible confounders of the personal care product use and exogenous estrogen 
association. However, the goal of this research was not to quantify the independent effects of 
personal care product use on estrogen exposure, but rather to illustrate a method for identifying 
important covariates for future studies of personal care product-health outcome associations. 
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3.6. Conclusion 
One active area of environmental health research is the investigation of associations 
between personal care product use and health outcomes [117-119]. This necessitates a thorough 
understanding of how exposures vary within a population and co-vary with other exposures. We 
identified patterns of personal care product use among a nationwide group of women and found 
that for white women, those with the highest level of exposure to personal care products also 
tended to have used exogenous hormone medications. Understanding and accounting for such 
relationships is critical as researchers explore associations between personal care product use and 
health outcomes.  
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Table 3.1. Descriptive characteristics of sample population 
 N % 
Race/ethnicity 
  Non-Hispanic White 42453 91% 
Non-Hispanic Black 4452 9% 
Menopausal status 
  Missing 264 0.6% 
Pre-menopausal 16550 35% 
Post-menopausal 30091 64% 
Highest level of education completed   
Missing 4 0 
<High school 369 0.8% 
HS or equivalent 6574 14% 
Some college but no degree 9185 20% 
Associate, technical or, Bachelor’s degree 19323 41% 
More than Bachelor’s 11450 24% 
Oral contraceptive use   
Missing 36 0.1% 
Never 7161 15% 
Ever 39708 85% 
Post-menopausal hormone therapy (HT)   
Missing 155 0.3% 
Never 23545 50% 
Ever 23205 49% 
Geographic location   
Missing 34 0.1% 
Northeast 8165 17% 
Midwest 13234 28% 
South 15574 33% 
West 9906 21% 
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Table 3.2. Indicators of fit for latent class analysis  
 AIC BIC Entropy 
Beauty classes    
2 78666 78993 0.77 
3 35717 36210 0.83 
4 29716 30378 0.79 
5 24355 25184 0.74 
6 22393 23390 0.71 
Hair classes   
2 14239 14459 0.96 
3 7936 8271 0.67 
4 5237 5686 0.61 
5 3416 3980 0.64 
6 2046 2725 0.67 
Skin classes   
2 48055 48381 0.72 
3 38337 38831 0.71 
4 30150 30812 0.73 
5 26769 27598 0.69 
6 24092 25089 0.67 
AIC: Akaike information criterion 
BIC: Bayesian information criterion 
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Table 3.3. Latent class distribution by race 
 Class descriptor White Black Total 
  N (%) N (%) N (%) 
Beauty Products     
Total  42558 4461 47019 
Beauty A Infrequent users 9231 (22%) 1282 (29%) 10513 (22%) 
Beauty B  Moderate users 16010 (38%) 2156 (48%) 18166 (39%) 
Beauty C Frequent users 16762 (39%) 746 (17%) 17508 (37%) 
Missing  555 (1%) 277 (6%) 832 (2%) 
     
Hair Products     
Total  42558 4461 47019 
Hair A Infrequent users of 
hair spray 
20950 (49%) 1011 (23%) 21961 (47%) 
Hair B  
 
Users of pomade and 
hair straightener 
1182 (3%) 2989 (67%) 4171 (9%) 
Hair C Frequent users of hair 
spray and hair gel 
19659 (46%) 173 (4%) 19832 (42%) 
Missing  767 (2%) 288 (6%) 1055 (2%) 
     
Skincare 
Products 
    
Total  42558 4461 47019 
Skin A  Infrequent users 7954 (19%) 812 (18%) 8766 (19%) 
Skin B  Moderate users 18617 (44%) 2192 (49%) 20810 (44%) 
Skin C  Frequent users 10271 (24%) 551 (12%) 10822 (23%) 
Skin D Talcum powder users 5158 (12%) 628 (14%) 5786 (12%) 
Missing  558 (1%) 278 (6%) 836 (2%) 
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Table 3.4. Latent class descriptions by product category 
Category/class  Label Description 
Beauty 
product 
classes 
A Infrequent users Infrequent use of eye shadow, eyeliner, 
mascara, foundation, and blush; relatively (to 
the other classes) infrequent use of make-up 
remover, perfume, and lipstick. 
B Moderate users Intermediate use of eye shadow, 
ner, mascara, foundation, blush, make-up 
over, perfume and lipstick (relative to the 
r classes). 
C Frequent users Frequent use of eye shadow, eyeliner, 
mascara, foundation, blush, make-up remover, 
nail polish, and lipstick. 
Hair product 
classes 
A Infrequent users of 
hair spray 
Relatively infrequent use of hair spray,  hair 
gel compared to Hair-C (similar to class Hair-
B); frequent use of shampoo, conditioner; 
infrequent use of pomade and hair straightener  
B Users of pomade and 
hair straightener 
Infrequent use of shampoo, hair gel; 
intermediate use of pomade, hair straightener, 
and hair spray 
C Frequent users of hair 
spray and hair gel 
Frequent use of hair spray, hair gel,  shampoo, 
conditioner; infrequent use of pomade and hair 
straightener 
Skincare 
product 
classes 
A Infrequent users Infrequent use of lotions, creams, talcum 
powder 
B Moderate users Intermediate use of lotions, creams; infrequent 
use of talcum powder 
C Frequent users Frequent use of face creams and lotions; 
infrequent use of talcum powder 
D Talcum powder users Second most frequent use of lotions; most 
frequent use of talcum powder 
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Figure 3.1. Item-response probabilities for frequency of personal care product use, conditional on 
class membership 
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Figure 3.2. Spearman correlation coefficients of posterior probabilities of latent class 
membership for beauty products, hair products, and skincare products among (A) white and (B) 
black women 
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Figure 3.3. Difference in prevalence of ever use of OCs and HTs by latent class membership 
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CHAPTER 4: ASSOCIATION BETWEEN PERSONAL CARE PRODUCT USE 
PATTERNS AND BREAST CANCER RISK IN THE SISTER STUDY 
 
4.1. Overview 
Background: It is hypothesized that certain chemicals in personal care products may increase 
risk of breast cancer. The primary aim of this study was to evaluate whether patterns of beauty, 
hair, or skin-related personal care products, or individual products, were associated with breast 
cancer. 
Methods: We evaluated data from non-Hispanic black and white women (N=46,905) in The 
Sister Study, a national prospective cohort study of breast cancer risk due to environmental and 
genetic exposures. Latent class analysis (LCA) was used to identify groups of individuals with 
similar patterns of personal care product use at cohort enrollment in 2003-2009. Multivariable 
Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence 
intervals (CIs) for the association between product use and breast cancer risk.  
Results: A total of 2,328 women developed breast cancer during follow-up (average follow-up= 
5.4 years). Among white women, those classified as ‘moderate’ and ‘frequent’ users of beauty 
products had increased risk of breast cancer relative to ‘infrequent users’ (HR=1.13; 95% CI: 
1.00-1.27 and HR=1.15; 95% CI: 1.02-1.30,  respectively).  ‘Frequent’ users of skincare products 
also had increased risk of breast cancer relative to ‘infrequent users’ (HR=1.13; 95% CI: 1.00-
1.29). Numbers for black women were too sparse for most analyses. None of the hair product 
classes were associated with increased breast cancer risk in either black or white women. In 
stratified analyses, the associations were more apparent in post-menopausal white women.   
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Conclusions: This work generates novel hypotheses about personal care product use and breast 
cancer risk. Users of specific classes of personal care products appear to differ in their breast 
cancer risk.  Whether these results are due to specific chemicals to other correlated behaviors 
needs to be evaluated. 
Conclusions: Users of specific classes of personal care products appear to differ in their breast 
cancer risk.  Whether this difference is due to specific chemicals in these products or to other 
correlated behaviors should be evaluated.   
4.2. Introduction 
There is concern that use of personal care products (e.g., cosmetics, lotions, and 
fragrances) may be associated with breast cancer risk [67]. These products are a possible source 
of human exposure to endocrine disrupting chemicals, such as phthalates, parabens, and phenols 
[79, 97, 101, 120]. These chemicals have been linked to risk of reproductive and other 
endocrine-related cancers [121-124], and have been hypothesized to mimic the carcinogenic 
effects of estrogenic exposures [98, 99]. 
Women are the primary consumers of many personal care products and are 
disproportionately exposed to these chemicals [125].  A survey of more than 2,300 women 
reported that the average adult woman uses approximately 12 individual personal care products 
each day and that more than a quarter of all women use at least 15 products daily [77]. A cross-
sectional analysis of women in northern Mexico reported that increased personal care product 
use was associated with higher urinary concentrations of monoethyl phthalate (MEP) [100]., a 
phthalate used in a range of personal care products [126]. The Environmental and Reproductive 
Health [EARTH] Study, a cohort study of women ages 18 to 45 years, reported evidence of a 
monotonic dose-response relationship between number of products used and urinary paraben and 
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phthalate metabolite concentrations [101]. However, few studies have evaluated the association 
between individual personal care products, or components of products, and breast cancer risk. 
Studies of deodorant/antiperspirant and hair dye have not strongly supported an association 
between personal care product use and increasing risk of breast cancer [88-91, 102, 105, 106].  
However, a population based case-control study of women residing in northern Mexico, with 233 
histopathologically confirmed breast cancer cases and 221 age-matched controls, reported that 
exposure to MEP may be associated with increased risk of breast cancer [102]. However, the 
same study also reported that exposure to other phthalates used in personal care products (i.e., 
monobenzyl phthalate (MBzP) and mono (3-carboxypropyl) phthalate (MCPP)) was inversely 
associated with breast cancer [102].  
A challenge facing epidemiologic studies of personal care products lies in the fact that 
individual chemical exposures or personal care product usage may not capture overarching 
patterns of use across multiple products.  We have previously observed that there are unique 
patterns of personal care product use, and these patterns were associated with breast cancer risk 
factors [127]. In this current work, we evaluated patterns of beauty, hair, and skin -related 
personal care product use in association with breast cancer risk.  
4.3. Methods 
4.3.1. Study Design and Population  
The Sister Study is a prospective cohort directed at identifying environmental and genetic 
risk factors for breast cancer and enrolled 50,884 women in the continental United States and 
Puerto Rico during 2003-2009. Eligible women were 35-74 years of age and had at least one 
sister diagnosed with breast cancer but were cancer-free themselves at enrollment. Enrollment 
activities included a computer-assisted telephone interview and self-administered questionnaires 
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that elicited information about environmental and reproductive exposures. The Sister Study was 
approved by the institutional review boards at the National Institute of Environmental Health 
Sciences and Copernicus Group. All study participants provided written informed consent.  
4.3.2. Breast cancer ascertainment 
Participants reported breast cancer diagnoses on annual and biennial health 
questionnaires, or by calling the Sister Study helpline. Women who reported an incident breast 
cancer during follow-up were asked to authorize release of pertinent medical records. Response 
rates were >94% over follow-up [109].  Among participants in our sample population, 2,328 
breast cancers were reported during 304,034 person-years (average follow-up ~5.4 years). By the 
time of the present analysis, pathology reports or medical records had been obtained for >80% of 
these cases (n=1,923).  Confirmation of self-reported breast cancer diagnoses by medical record 
was very high [positive predictive value (PPV)=99.5%] [110]. After medical record review, self-
reported ER status information was confirmed for 99% of ER positive cases, and 85% of ER 
negative cases.  Because agreement between self-reported and medical abstracted data was high, 
we used self-reported tumor information when medical records were not available. 
4.3.3. Personal care product exposure 
Self-reported use of 48 personal care products was collected during the baseline phase of the 
study (Table A.4) by inquiring about frequency of use (5-level-response option) during the 
previous 12 months. To identify latent classes of personal care product use, responses were 
categorized according to three product types, with separate latent classes within each type: (1) 
beauty products, (2) hair products, and (3) skincare products [127]. To reduce dimensionality, 
improve interpretability of the model, and improve classification and precision we  selected the 
personal care products that were most useful for distinguishing between latent classes (i.e., ≥10% 
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difference in posterior probabilities between classes) Dean et al. [108]. Variables that did not 
contribute to the distinction between latent classes were removed from the model. Within each 
product category, latent classes were described and considered as exposure groups with the 
labels described in Table 1.  
 Starting with 48 individual personal care product use questions, we reduced data 
dimensionality by identifying fourteen initial beauty product types.  These were further reduced 
to nine contributing product items (Supplemental Table 1) and three latent classes. Analysis of 
fifteen hair product types was reduced to six contributing products and three latent classes. 
Finally, analysis of nineteen skincare product types was reduced to nine contributing products 
and four latent classes. 
4.3.4. Statistical Analyses 
The present analysis was limited to non-Hispanic white (n=42,453, 91%) and non-
Hispanic black (n=4,452, 9%) women (Table 2). Multivariable Cox proportional hazards models 
were used to estimate adjusted hazard ratios (adjHR) and 95% confidence intervals (CI) for the 
association between the personal care product latent classes and breast cancer risk. Statistical 
models used age as the time scale, where participants entered the analysis at their enrollment age 
(left-truncation) and accrued person-time until they exited at their cancer diagnosis or were 
administratively censored at their age at last follow-up. In analyses investigating associations by 
menopausal status at the time of breast cancer diagnosis, women who became postmenopausal 
during the follow-up period were censored at the time of menopause and the person-time that 
accumulated after menopause contributed to postmenopausal person-time at risk. The 
proportional hazards assumption was visually assessed using ln-ln survival plots; there was no 
suggestion of time-variant associations. 
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All models were stratified by race. Women who reported that they had undergone natural 
menopause, hysterectomy, bilateral oophorectomy, irradiation to the ovaries, or otherwise 
reported cessation of menstruation were classified as post-menopausal; women who reported that 
they were still cycling were classified as pre-menopausal. The following covariates, measured at 
baseline, were included in adjusted models: menopausal status at baseline (pre-menopausal or 
post-menopausal), age at menarche (<12 years or ≥12 years), age at first birth (nulliparous, <26 
years, or ≥26 years), parity (nulliparous, 1-2 children, or ≥3 children) , duration of breastfeeding 
(<12 months or ≥12 months), oral contraceptive (OC) use (ever or never), post-menopausal 
hormone therapy (HT) use among women >50 years (ever or never), education (< high school or 
≥high school), alcohol consumption (never drinker, former drinker, currently drink <1 drink/day 
or currently drink ≥1 drink/day), adult body mass index (BMI) (<25kg/m2, 25 to <30kg/m2, or 
≥30 kg/m2), family history (having one sister with breast cancer or ≥1 sister and/or a mother with 
breast cancer), smoking status (never smoker, former smoker, current smoker), and current 
region of residence (West, South, North, East). In sensitivity analyses among post-menopausal 
white women only, models were stratified by ER status (ER positive or ER negative according to 
the clinical record), and breast cancer type (in situ or invasive). 
We also explored HRs for individual product types, using Bonferroni correction to adjust 
for multiple comparisons (p-value ≤ 0.001) .  For all analyses, results are presented that included 
at least 20 exposed breast cancer cases.  All analyses were performed using SAS statistical 
software (version 9.3; SAS Institute Inc, Cary, NC).  
4.4. Results 
During the 304,034 person-years contributed by 46,905 women, 2,328 breast cancers 
were diagnosed (average follow-up ~5.4 years).  We recognize that the latent classes shown in 
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Table 1 reflect complex patterns of exposure that may appear oversimplified by the label; 
however these labels are used to improve clarity of presentation. Cohort characteristics along 
with the complete profile associated with these labels has been reported previously [127] and is 
described briefly here:   
Among the 24 beauty products considered, nine contributed to the latent classes. 
Compared to the ‘infrequent’ beauty product user latent class, women in the ‘frequent’ user class 
were more likely to report the most frequent use of all nine products: eye shadow, eyeliner, 
mascara, foundation, make-up remover, nail polish perfume, blush, and lipstick. Women in the 
‘moderate’ beauty user class reported the second most frequent use of the same products, 
excluding blush. Among the original nineteen skincare products, there were nine products that 
contributed to the latent classes. Compared to the other latent classes, women in the ‘frequent 
user’ skincare latent class were most likely to be frequent users of cleansing cream, anti-aging 
cream, body lotion, face cream, and foot cream. These women had moderate use (relative to 
other latent classes) of hand lotion and petroleum jelly and were the most infrequent users of 
talcum powder (underarms and ‘other’).  
Among white women, ‘moderate users’ and ‘frequent users’ of beauty products had 
increased risk of breast cancer relative to ‘infrequent users’ (adjHR= 1.13; 95% CI, 1.00-1.27 
and adjHR=1.15 (1.02, 1.30) (Table 3.2). Among white women, ‘frequent users’ of skincare 
products had increased risk of breast cancer relative to infrequent use (adjHR= 1.13; 95% CI, 
1.00-1.29. The associations were not significantly nor appreciably elevated among black women; 
however, there were only 165 breast cancer cases among blacks (Table 3.2).  Neither beauty nor 
skincare product use appeared to be associated with increased breast cancer risk among black 
women.    
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In analyses that were restricted to white women and stratified by menopausal status, HRs 
for breast cancer associated with frequent (compared to infrequent) use of beauty or skincare 
products were slightly higher among post-menopausal women (adjHR=1.18 and 1.12,  
respectively)  than pre-menopausal women (adjHR = 1.01 and 1.06, respectively) but were not 
statistically different (p-interaction >0.3) (Table 3.3). Other latent class membership did not 
appear to be associated with breast cancer risk. 
In sensitivity analyses ER status was available for 89% (N=1,467) of white post-
menopausal women. In this group, ‘moderate’ and ‘frequent’ users (compared to infrequent 
users) of beauty products did not appear to differ substantially between ER+ (adjHR=1.05; 95% 
CI: 0.90-1.23 and adjHR=1.10; 95% CI: 0.94-1.28) and ER- (adjHR=1.03; 95% CI: 0.69-1.54 
and adjHR=0.72; 95% CI: 0.47-1.10). When stratified by breast cancer type, white  post-
menopausal ‘moderate’ and ‘frequent’ users of beauty products had increased risk of in situ 
(adjHR=1.41; 95% CI: 1.06-1.89 and adjHR=1.38; 95% CI: 1.03-1.85) but not invasive breast 
cancer (adjHR=1.09; 95% CI: 0.94-1.27 and adjHR=1.13; 95% CI: 0.97-1.32). We also 
conducted exploratory analyses of the 24 individual products included in LCA. However, after 
adjusting for Bonferroni criteria (p-value ≤ 0.001) none were associated with breast cancer 
(Table A.7). 
4.5. Discussion 
Our findings from this large, prospective study with detailed self-report of personal care 
product use suggest that membership in the ‘moderate’ and ‘frequent’ users of beauty products  
latent class was associated with an  approximately 10-15% increased risk of developing breast 
cancer compared to ‘infrequent’ users. Among post-menopausal women the increase in risk was 
slightly greater. ‘Frequent users’ of beauty products can be broadly categorized as women who 
 
 
53 
 
report using a combination of beauty products on a weekly basis (e.g., mascara, foundation, and 
lipstick). ‘Moderate’ users were more likely to report using these same products at least monthly 
or up to several times a month.  One latent class of skincare product, ’frequent users’, was also 
associated with an approximate 13% increased risk of breast cancer. ‘Frequent users’ were more 
likely to report at least weekly use of a combination of skincare products, such as lotions and 
creams. Like the beauty product latent classes, when compared to pre-menopausal women, the 
magnitude of the association for ‘frequent’ users of skincare products was stronger among post-
menopausal women. 
The hypothesis that personal care products are associated with increased breast cancer 
risk is primarily based on animal and laboratory studies. In these settings,  chemicals found in a 
wide variety of personal care products (e.g., parabens and phthalates) mimic estrogens [73], alter 
hormonal signaling, affect developing reproductive systems [80], and/or disrupt normal 
mammary development [81]. We found the association between both beauty and skincare latent 
classes and breast cancer risk to be slightly stronger among post-menopausal women. This is 
consistent with the hypothesis that weak estrogenic effects might be more impactful during the 
post-menopausal period as women with lower endogenous estrogen levels are more susceptible 
to exogenous estrogenic exposures. Post-menopausal women are older on average than pre-
menopausal women, so it is also likely that they have accumulated exposure or longer duration 
of exposure to personal care products. However, because associations are stronger for in situ and 
not invasive breast cancer, it is possible that the results for in situ are driving the associations for 
overall breast cancer risk. These results may also suggest that increased risk of breast cancer 
among beauty product users is driven more by behavioral factors than chemical exposure. For 
example, women who are more frequent users of beauty products may be more likely to undergo 
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more frequent screenings and mammograms and thus be more likely to have a carcinoma in situ 
detected.  
Personal care product exposure is difficult to characterize because each product is a 
complex mixture and multiple products are often used in combination by one person.  Co-
occurring exposures may have additive or interacting effects or may result in confounding. For 
example, a chemical that does not show estrogenic activity could be a marker for other chemicals 
that are estrogenic. Products that include chemicals that can be estrogenic may show either 
estrogenic or anti-estrogenic effects in specific tissues [128]. Previous studies have examined 
correlation structure between specific personal care products [92-94], but these studies did not 
evaluate associations between personal care product use and health outcomes.  
Our study addressed the idea that combinations and patterns of exposure may be 
especially important in relation to risk.  The large sample size of white women, detailed self-
report of personal care product use, prospective identification of breast cancer, multivariable 
analysis, and inclusion of both the aggregated and individual exposure data strengthen our study. 
This work should be interpreted in light of some limitations. First, we had limited power 
to examine associations among black women. The Sister Study questionnaire did not capture 
information on specific brands of personal care products or the individual components of these 
products. However, even if product brand information were available, manufacturers are not 
required to disclose all chemical ingredients in consumer products [118]. Chemical composition 
of products change over time and across batches and chemicals (e.g., BPA) can leach from 
containers into the product [129]. Thus, individual chemical exposures are not feasible to 
ascertain from the questionnaire data. 
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Although information on product ingredients was not available, the personal care 
questionnaire measured current exposure, defined as patterns within the last twelve months. This 
information is most useful if exposure is relatively constant over time.  In our study, the average 
follow-up was ~5.4 years, and therefore, it is likely that exposure was reasonably well captured 
over shorter intervals.  We did not have information on duration of use of specific products.  If 
the relevant time window is years in the past, it is not clear that current patterns will be relevant.  
However, since the use classes are quite broad, it seems reasonable to assume that they are a 
general approximation of adult behavior patterns. 
Confounding by indication should be considered when interpreting the exposure patterns 
in this study. Underlying or latent biological factors may determine certain patterns of use. The 
goal of LCA is to capture groups of people with shared behaviors or traits that may not be 
measured or observed in the data. Thus, it is possible that a latent class may capture individuals 
with a shared, unmeasured characteristic that increases susceptibility to breast cancer or it could 
capture early, undiagnosed breast cancer. For example, it is possible that frequent use of skincare 
products or beauty products represent a latent class that shares a common set of skin conditions, 
along with use of medications for those skin conditions. There have been studies suggesting that 
certain skin conditions associated with hormone imbalance (e.g., acne or rosacea) may be 
associated with breast cancer risk [130-133]. Acne is suspected to be a result of high levels of 
circulating androgens which have been associated with breast cancer in prospective studies [130, 
131].  Other indicators for skin conditions should also be considered. Radiotherapy treatment for 
acne and other skin conditions has also been positively associated with breast cancer [134, 135]. 
Antibiotics, often used to treat acne and other skin conditions, have also been associated with 
increased risk of breast cancer [132, 136, 137]; though other studies of antibiotic use and breast 
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cancer have found no association [138-140]. We have previously shown that frequent use of 
beauty and skincare products is associated with exogenous hormone exposure [127].  While a 
number of covariates were included in this analysis, underlying skin conditions were not 
available. 
4.6. Conclusion 
The results from this study generate novel hypotheses concerning the relationship 
between use of personal care products and risk of female breast cancer. Users of specific classes 
of personal care products appear to differ in their breast cancer risk.  Whether this is due to 
specific chemicals in the products or to other correlated behaviors, such as early and/or frequent 
breast cancer screenings, needs to be evaluated. Future studies are needed to replicate these 
findings and examine biological pathways by which these complex exposures influence breast 
cancer risk. For example, future studies might address medication used to treat skin conditions. 
Future work should also address duration of exposure and how product use patterns vary over 
time, perhaps by re-administering the same questionnaire on personal care product use among to 
a sample of the Sister Study population at additional follow-up intervals.  
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Table 4.1. Latent class descriptions by product category 
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Table 4.2. Hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between 
personal care product latent classes and overall breast cancer risk among white and black 
women 
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Table 4.3. Hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between 
latent classes and breast cancer risk among post-menopausal and pre-menopausal women white 
women 
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CHAPTER 5: DISCUSSION 
5.1. Brief summary of findings 
Using data from a large study of United States women, we identified subgroups of 
women with distinct personal care product use exposure. Personal care product exposure is 
difficult to characterize because each product is a complex mixture and multiple products are 
often used in combination by one person.  These co-occurring exposures may have additive or 
interacting effects or may result in confounding. Latent class analysis addresses these limitations 
by identifying latent classes which describe variability among multiple, correlated, and observed 
variables [107 714]. Three latent classes were identified for beauty products; four classes were 
identified for skincare products; and three classes were identified for hair care products. Our 
results suggest that relative to individual product use questions, latent class variables capture 
different dimensions of product use or other latent characteristics associated with product use.  
In Chapter 3 we emphasize the association between latent classes and exogenous 
hormone use (OC use and post-menopausal HT use among women >50 years). Having observed 
correlation within personal care product use classes (e.g. between frequent users of hair and 
beauty products), we tested whether personal care product categories are associated with OC and 
HT, examples of key exposures to exogenous estrogens. We found that the women with the 
highest use of personal care products are more likely to have used these common exogenous 
hormone medications. Therefore, when personal care product use is being evaluated as a 
potential risk factor for hormonally-mediated conditions, we encourage researchers to consider 
possible confounding by OC and HT use. However, OC and HT use are only two examples; a 
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wide range of associations between latent classes and other breast cancer risk factors (Table 2.1) 
were also considered (Table A.6). While the LCA approach addresses complex exposure patterns 
within personal care products, it is also important to integrate product use patterns with other 
biologically relevant and risk-related exposures.  
The overall goal of this analysis was to examine personal care product use in association 
with breast cancer risk. Chapter 4 provides some evidence that certain classes of beauty product 
and skincare product users may be at increased risk of breast cancer. However, we cannot 
distinguish whether the association is related to specific chemical components in the products or 
if it is due to a characteristic or correlated behavior of the women in the latent classes 
themselves. The goal of LCA is to capture groups of people with shared behaviors or traits that 
may not be measured or observed in the data. Thus, it is possible that a latent class may capture 
individuals with a shared, unmeasurable biological characteristic that itself increases 
susceptibility to breast cancer. Therefore, confounding by indication should be considered when 
interpreting the exposure patterns in this study.  For example, it is possible that frequent use of 
skincare products or beauty products represent a latent class that shares a common set of skin 
conditions, along with use of medications for those skin conditions. 
5.2. Biological plausibility  
The concern that use of personal care products may be associated with breast cancer risk 
is based on the hypothesis that chemicals in personal care products (e.g., parabens and 
phthalates) may act as endocrine disrupting chemicals (EDCs) [67, 79, 97, 103, 104], possibly 
mimicking the carcinogenic effects of estrogenic exposures [98, 99]. One product can be a 
source of many chemicals and use of multiple products can result in exposure to an even larger 
number of chemicals [79]. We found the association between both beauty and skincare latent 
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classes and breast cancer risk to be slightly stronger among post-menopausal women. However, 
among pre-menopausal women, we found no association. This is consistent with, though not 
confirmative of, the hypothesis that weak estrogenic effects might be more impactful during the 
post-menopausal period as women with low estrogenic levels are more susceptible to estrogenic 
exposures. Because they are older on average than pre-menopausal women, is also likely that 
post-menopausal women have more accumulated exposure to personal care products due to 
longer duration of use. These results may also suggest that increased risk of breast cancer among 
beauty product users is driven more by behavioral factors than chemical exposure. For example, 
women who are more frequent users of beauty products may be more likely to undergo more 
frequent screenings and mammograms and thus be more likely to have an early breast cancer 
detected. 
Although the Sister Study’s questionnaire did not have information on duration of 
exposure, we were able to examine detailed information on the frequency of use of 48 personal 
care products. The questionnaire measured current exposure, defined as product use over the past 
twelve months. Among white women in our sample population, the average follow-up is ~5.4 
years, and therefore, it is likely that exposure was reasonably well captured over shorter 
intervals.  However, if exposure varies over shorter intervals, exposure may have been 
misclassified. However, if we assume that the mechanisms of action for personal care products 
involve tumor growth/maintenance rather than initiation, the timing of exposure is likely to be 
relevant. 
5.3. Significance and future direction 
To our knowledge, this was the first study to do two things: (1) use LCA to categorize 
exposure to personal care products, and (2) examine the association between aggregate personal 
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care product use and breast cancer. Previous studies have examined the co-use of personal care 
products [92-94], but these studies were not aimed at reducing the complexity of individual 
product usage patterns. Nor did these studies examine how product use relates to other exposures 
or health outcomes. Surprisingly, this study was the first to examine the association between 
overarching patterns of personal care product use and breast cancer. When considering personal 
care product use in association with a health outcome, it is important to integrate these exposures 
with other biologically relevant and risk-related exposures. We observed correlation within 
personal care product use classes (e.g. between heavy users of hair care products and heavy users 
of beauty products) and examined how product use relates to other relevant exposures. 
Understanding and accounting for such relationships is critical as researchers explore 
associations between personal care product use and health outcomes. Future studies of other 
health outcomes measured in the Sister Study that have a suspected link to personal care product 
use (e.g., other cancers, asthma, etc.) should consider these latent classes. 
In addition to considering latent classes as potential covariates for other relevant health 
outcomes, future work should also address how product use patterns vary over time. The 
exposure measured by the questionnaire is most useful in relation to evaluating health outcomes 
with longer empirical induction periods if it captures exposure that is relatively constant over 
time. This could be examined in the Sister Study by re-administering the same questionnaire on 
personal care product use among to a sample of the Sister Study population at additional follow-
up intervals. Another issue regarding exposure as measured by the questionnaire relates to the 
validity of the questionnaire. Information collected from the personal care questionnaire provides 
extensive data related to the frequency and pattern of personal care product use. However, 
because the information was self-reported, a limitation of the personal care questionnaire 
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includes potential recall bias. In addition, chemical-specific exposures cannot be ascertained 
from the questionnaire data. To address these limitations we are currently developing a study at 
the National Toxicology Program to evaluate the effectiveness of the personal care questionnaire 
by jointly assessing product use via daily diary, product photographs, and biomonitoring.  
The results from this study generate novel hypotheses for breast cancer risk. Our results 
suggest that relative to individual product use questions, latent class variables capture different 
dimensions of product use or other latent characteristics associated with product use. Users of 
specific classes of personal care products appear to differ in their breast cancer risk.  Whether 
this is due to specific chemicals in the products or to other correlated behaviors, such as early 
and/or frequent breast cancer screenings, needs to be evaluated. Future studies are needed to 
replicate these findings and examine biological pathways by which these complex exposures 
influence breast cancer risk. For example, future studies might address medication, or additional 
product types, used to treat skin conditions. LCA is a valuable tool as it identifies groups of 
people with shared behaviors or traits that may not be measured or observed in the data. 
Therefore, rather than assuming that the observable data used to create a latent class is 
etiologically relevant to an associated health outcome, results of LCA must be interpreted with 
the knowledge that a latent class may instead be capturing individuals with a shared, 
unmeasurable biological characteristic that itself increases susceptibility to disease. 
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APPENDIX A: TABLES 
Table A.1. Item response probabilities for beauty product latent classes (3 class model) 
 
Beauty A 
Infrequent user 
Beauty B 
Moderate user 
Beauty C 
Frequent user 
Class prevalence 23% 40% 38% 
Mascara    
Never 0.7667 0.1243 0.0698 
<once a month to 1-3 times a month 0.1154 0.3885 0.0970 
1 to 5+ times a week 0.1179 0.4872 0.8331 
Lip Stick    
Never 0.3967 0.0524 0.0405 
<once a month to 1-3 times a month 0.2336 0.2925 0.0998 
1 to 5+ times a week 0.3697 0.6551 0.8597 
Foundation    
Never 0.6976 0.1876 0.1001 
<once a month to 1-3 times a month 0.2077 0.7498 0.1499 
1 to 5+ times a week 0.0947 0.0626 0.7500 
Nail Polish    
Never 0.4344 0.1112 0.0573 
<once a month 0.3917 0.4721 0.3500 
1-3 times a month or more 0.1740 0.4167 0.5927 
Perfume    
Never 0.3746 0.1461 0.1272 
<once a month to 1-3 times a month 0.3482 0.3872 0.2626 
1 to 5+ times a week 0.2772 0.4667 0.6102 
Eye shadow    
Never 0.9041 0.1514 0.1240 
<once a month to 1-3 times a month 0.0816 0.8169 0.3025 
1 to 5+ times a week 0.0143 0.0316 0.5735 
Eyeliner    
Never 0.8962 0.3394 0.2383 
<once a month to 1-3 times a month 0.0632 0.6043 0.2045 
1 to 5+ times a week 0.0406 0.0563 0.5572 
Blush    
Never 0.6850 0.1404 0.0682 
<once a month to 1-3 times a month 0.2290 0.8071 0.1401 
1 to 5+ times a week 0.0861 0.0529 0.7916 
Makeup-remover    
Never 0.9480 0.5417 0.4562 
<once a month to 1-3 times a month 0.0406 0.4347 0.2371 
1 to 5+ times a week 0.0113 0.0237 0.3068 
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Table A.2. Item response probabilities for hair product latent classes (3 class model) 
 
Hair A 
Infrequent user of 
hair styling 
products 
Hair B 
Infrequent user of 
shampoo 
Hair C 
Frequent user of 
hair styling 
products 
Class prevalence 48% 43% 9% 
Pomade    
Never 0.9074 0.8803 0.4235 
<once a month to 1-3 times a month 0.0588 0.0602 0.3930 
1 to 5+ times a week 0.0338 0.0594 0.1836 
Hair Straightener    
Never 0.9442 0.9782 0.4797 
<once a month to 1-3 times a month 0.0390 0.0170 0.2638 
1 to 5+ times a week 0.0167 0.0048 0.2565 
Conditioner    
never to <once a month 0.1897 0.1991 0.1572 
1-3 times a month 0.0770 0.0865 0.8163 
1 to 5+ times a week  0.7334 0.7144 0.0265 
Hair Spray 
  
 
Never 0.4463 0.0606 0.3835 
<once a month to 1-3 times a month 0.3387 0.1529 0.4532 
1 to 5+ times a week 0.2151 0.7865 0.1604 
Hair Gel 
  
 
Never 0.4001 0.0602 0.4089 
<once a month to 1-3 times a month 0.3766 0.1279 0.4946 
1 to 5+ times a week 0.2233 0.8119 0.0964 
Shampoo    
Never to 1-3 times a month 0.0094 0.0040 0.9802 
1 to 5 times a week 0.6337 0.4857 0.0198 
>5 times a week 0.3569 0.5102 0.0000 
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Table A.3. Item response probabilities for skincare product latent classes (4 class model) 
 Skin A Skin B Skin C Skin D 
 
Infrequent 
users 
Moderate 
users 
Frequent 
users 
Talcum 
powder users 
     
Class prevalence 19% 73% 24% 14% 
Cleansing Cream     
Never 0.8336 0.4264 0.4084 0.3908 
<once a month to 1-3 times a month 0.1197 0.1448 0.2367 0.2500 
1 to 5+ times a week 0.0467 0.4287 0.3549 0.3592 
Anti-aging Cream     
Never 0.8576 0.3407 0.3000 0.3619 
<once a month to 1-3 times a month 0.1090 0.1540 0.2750 0.2291 
1 to 5+ times a week 0.0334 0.5053 0.4250 0.4090 
Body Lotion     
Never to <once a month 0.3630 0.0270 0.0932 0.0410 
<once a month to 1-5 times a week 0.5054 0.1015 0.8378 0.3386 
>5 times per week 0.1316 0.8716 0.0690 0.6204 
Hand Lotion     
Never to 1-3 times a month  0.4356 0.0282 0.2447 0.0626 
1 to 5 times a week  0.3320 0.0907 0.6111 0.2269 
>5 times a week  0.2324 0.8811 0.1442 0.7105 
Face Cream     
Never to <once a month 0.5550 0.0343 0.0180 0.0587 
<once a month to 1-5 times a week 0.2441 0.0911 0.4005 0.2191 
>5 times per week 0.2009 0.8746 0.5815 0.7222 
Foot Cream     
Never 0.5705 0.1980 0.2505 0.1528 
<once a month to 1-3 times a month 0.3374 0.3350 0.5682 0.4172 
1 to 5+ times a week 0.0921 0.4671 0.1813 0.4300 
Petroleum Jelly     
Never 0.7518 0.6196 0.7344 0.5065 
<once a month to 1-3 times a month 0.1773 0.2129 0.2178 0.3053 
1 to 5+ times a week 0.0708 0.1675 0.0478 0.1882 
Talcum powder Underarms     
Never 0.8918 0.9643 0.9376 0.1672 
Once a month 0.0512 0.0216 0.0507 0.3371 
1-3 times a month or more 0.0570 0.0142 0.0117 0.4957 
Talcum powder other     
Never 0.6896 0.7568 0.7024 0.0000 
Once a month 0.1369 0.1395 0.1925 0.2725 
1-3 times a month or more 0.1735 0.1037 0.1051 0.7275 
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Table A.4. Initial product types and final product types by category: beauty, hair, skincare 
products 
Initial personal care products from personal care questionnaire by category (beauty, hair, and 
skin) 
     Beauty (14) Hair (15) Skin (19) 
        Mascara  Shampoo  Cleansing cream 
       Eyeshadow  Conditioner  Face cream 
       Eyeliner  Hair spray Face mask 
       Lip moisturizer Hair gel Shaving cream 
       Lip stick Pomade  Anti-aging cream 
       Foundation  Hair dye-permanent Age spot remover 
       Blush  Hair dye-semi permanent Self-tanner 
       Makeup remover Hair highlighter Baby oil 
        Nail polish Hair straightener Petroleum Jelly 
       Nail polish remover Hair color rinse Body lotion 
       Artificial nails Hair food Hand lotion 
       Artificial nails (other) Hair bleach Foot cream 
       Perfume  Hair perm Deodorant 
       Cuticle cream Rogaine Talcum underarms 
       
 
Hair straightener (other) Talcum other 
       
  
Talcum vaginal 
       
  
Bath gel 
        
  
Skin lightener 
       
  
Blemish cream 
       
           Reduced  personal care products used in the latent class analyses by category (beauty, hair, and skin) 
     Beauty (9) Hair (6) Skin (9) 
        Mascara  Shampoo  Cleansing cream 
       Eyeshadow  Conditioner  Anti-aging cream 
       Eyeliner  Hair spray Body lotion 
       Lip Stick Hair gel Hand lotion 
       Foundation  Pomade  Foot cream 
       Blush  Hair straightener Face cream 
       Makeup remover 
 
Petroleum Jelly 
       Nail polish 
 
Talcum underarms 
       Perfume 
 
Talcum other 
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Table A.5. Re-categorization of original response options by product 
 
New categories 
Original categories (1=did not use; 
2=<once a month; 3=1-3 times a 
month; 4=1-5 times a week; 5=> 5 
times a week 
  
 
Skincare Products  
Body Lotion Never to <once a month 1,2 
Multiple times a month to 1-5 
times a week 
3,4 
>5 times per week 5 
 
Hand Lotion Never to 1-3 times a month 1,2,3 
1 to 5 times a week 4 
>5 times a week 5 
 
Face Cream Never to <once a month 1,2 
 Multiple times a month to 1-5 times 
a week 
3,4 
 >5 times per week 5 
 
 
Cleansing Cream Never to <once a month 1,2 
1-3 times a month 3 
1 to 5+ times a week 4,5 
 
Anti-age cream Never 1 
<once a month to 1-3 times a month 2,3 
1 to 5+ times a week 4,5 
 
Foot cream Never 1 
<once a month to 1-3 times a month 2,3 
1 to 5+ times a week 4,5 
 
Baby oil Never 1 
<once a month to 1-3 times a month 2,3 
1 to 5+ times a week 4, 5 
 
Petroleum Jelly Never         1 
<once a month to 1-3 times a month       2,3 
1 to 5+ times a week       4,5 
 
Cuticle Cream Never 1 
<once a month 2 
1-3 times a month or more 3, 4, 5 
 
Hair Products 
Hair Spray Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
 
Hair Gel Never 1 
<once a month to 1-3 times a 
month 2,3 
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1 to 5+ times a week 4,5 
 
Conditioner 
Never to <once a month 1,2 
1-3 times a month 3 
1 to 5+ times a week 4,5 
 
Pomade Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
 
Hair Straightener Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
 
Beauty Products 
Mascara Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
 
Foundation Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
 
Lipstick Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
 
Lip moisturizer Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
 
Nail Polish Never 1 
<once a month 2 
1-3 times a month or more 3, 4, 5 
 
Perfume Never 1 
<once a month to 1-3 times a 
month 2,3 
1 to 5+ times a week 4,5 
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Table A.6. Age-adjusted prevalence differences (PDs) and 95% confidence intervals (CIs) 
for associations between breast cancer risk factors and latent classes within each product 
category 
Variable Comparis
on 
Latent class Class labels PD  (95% CI) PD  (95% CI) 
    White women Black women 
Menopausal 
status 
Pre- vs.  
Post-meno 
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.11 (0.10, 0.12) 0.09 (0.06, 0.12) 
  Beauty C Frequent users 0.11 (0.10, 0.12) 0.06 (0.01, 0.10) 
 Pre- vs.  
Post-meno 
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
-0.05 (-0.05, -
0.04) 
-0.05 (-0.08, -0.02) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.02 (0.01, 0.03) -0.01 (-0.05, 0.03) 
 Pre- vs.  
Post-meno 
(ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.02 (0.01, 0.03) -0.03 (-0.06, 0.00) 
  Skin C Frequent users 0.06 (0.05, 0.08) -0.02 (-0.07, 0.03) 
  Skin D Talcum 
powder users 
-0.01 (-0.03, 
0.01) 
-0.02 (-0.07, 0.03) 
      
Age at 
menarche 
<12 years 
vs ≥12 
years (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users -0.01 (-0.03, 
0.00) 
0.00 (-0.04, 0.04) 
  Beauty C Frequent users -0.02 (-0.03, 
0.00) 
-0.03 (-0.08, 0.01) 
 <12 years 
vs ≥12 
years (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (0.00, 0.01) 0.02 (-0.01, 0.05) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.00 (-0.01, 
0.01) 
0.02 (-0.03, 0.06) 
 <12 years 
vs ≥12 
years (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users -0.02 (-0.03, 
0.01) 
-0.03 (-0.06, 0.01) 
  Skin C Frequent users -0.03 (-0.04, -
0.01) 
-0.06 (-0.12, 0.00) 
  Skin D Talcum 
powder users 
0.01 (-0.01, 
0.03) 
0.00 (-0.05, 0.06) 
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Parity 1-2 
Children 
vs. 
Nulliparou
s  (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.08 (0.07, 0.10) 0.01 (-0.04, 0.05) 
  Beauty C Frequent users 0.14 (0.13, 0.16) 0.00 (-0.06, 0.05) 
 3+ 
Children  
vs. 
Nulliparou
s  (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.08 (0.06, 0.10) -0.02 (-0.07, 0.03) 
  Beauty C Frequent users 0.12 (0.10, 0.13) -0.11 (-0.18, -0.05) 
 1-2 
Children 
vs. 
Nulliparou
s  (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
-0.01 (-0.02, 
0.00) 
0.01 (-0.03, 0.05) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.07 (0.05, 0.08) -0.05 (-0.11, 0.00) 
 3+ 
Children  
vs. 
Nulliparou
s  (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (-0.01, 
0.00) 
0.03 (-0.01, 0.08) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.05 (0.03, 0.06) -0.05 (-0.12, 0.02) 
 1-2 
Children 
vs. 
Nulliparou
s  (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.06 (0.04, 0.07) -0.06 (-0.1, -0.02) 
  Skin C Frequent users 0.06 (0.04, 0.08) -0.04 (-0.12, 0.03) 
  Skin D Talcum 
powder users 
0.04 (0.02, 0.06) -0.06 (-0.13, 0.01) 
 3+ 
Children  
vs. 
Nulliparou
s  (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.02 (0.01, 0.04) -0.08 (-0.10, -0.03) 
  Skin C Frequent users 0.06 (0.03, 0.08) 0.01 (-0.08, 0.09) 
  Skin D Talcum 
powder users 
0.03 (0.00, 0.05) -0.05 (-0.13, 0.03) 
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Age at first live 
birth 
≤26 years  
vs. 
Nulliparou
s  (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.09 (0.07, 0.11) -0.02 (-0.06, 0.03) 
  Beauty C Frequent users 0.15 (0.13, 0.16) -0.05 (-0.11, 0.01) 
 >26 years  
vs. 
Nulliparou
s  (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.07 (0.05, 0.09) 0.04 (-0.01, 0.09) 
  Beauty C Frequent users 0.11 (0.10, 0.13) 0.01 (-0.06, 0.08) 
 ≤26 years  
vs. 
Nulliparou
s  (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (-0.01, 
0.00) 
0.02 (-0.01, 0.06) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.08 (0.07, 0.10) -0.06 (-0.11, 0.00) 
 >26 years  
vs. 
Nulliparou
s  (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
-0.01 (-0.02, 
0.00) 
-0.01 (-0.05, 0.04) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.02 (0.00, 0.03) -0.05 (-0.11, 0.02) 
 ≤26 years  
vs. 
Nulliparou
s  (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.04 (0.03, 0.06) -0.07 (-0.11, -0.04) 
  Skin C Frequent users 0.06 (0.04, 0.08) -0.03 (-0.1, 0.04) 
  Skin D Talcum 
powder users 
0.05 (0.02, 0.07) -0.05 (-0.13, 0.01) 
 >26 years  
vs. 
Nulliparou
s  (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.05 (0.03, 0.06) -0.05 (-0.10, 0.00) 
  Skin C Frequent users 0.06 (0.04, 0.08) -0.02 (-0.11, 0.07) 
  Skin D Talcum 
powder users 
0.02 (-0.01, 
0.04) 
-0.05 (-0.14, 0.03) 
Duration of 
breastfeeding 
<12  vs. 
≥12 
months  
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.05 (0.04, 0.06) -0.05 (-0.1, 0.00) 
  Beauty C Frequent users 0.11 (0.09, 0.12) 0.01 (-0.06, 0.08) 
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 <12  vs. 
≥12 
months  
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.01 (0.00, 0.02) 0.00 (-0.05, 0.04) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.10 (0.09, 0.11) 0.04 (-0.02, 0.10) 
 <12  vs. 
≥12 
months  
(ref) 
Skin A  (ref) Infrequent 
users 
1  
  Skin B Moderate users 0.02 (0.01, 0.04) -0.01 (-0.06, 0.04) 
  Skin C Frequent users 0.01 (-0.01, 
0.03) 
-0.01 (-0.09, 0.07) 
  Skin D Talcum 
powder users 
0.02 (0.00, 0.04) 0.01 (-0.07, 0.09) 
OC use Ever vs. 
never  (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.12 (0.10, 0.14) 0.15 (0.10, 0.2) 
  Beauty C Frequent users 0.14 (0.12, 0.16) 0.17 (0.12, 0.23) 
 Ever vs. 
never  (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
-0.01 (-0.02, 
0.00) 
0.00 (-0.04, 0.04) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.07 (0.06, 0.08) 0.05 (0.00, 0.11) 
 Ever vs. 
never  (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.10 (0.08, 0.12) 0.11 (0.06, 0.16) 
  Skin C Frequent users 0.09 (0.07, 0.11) 0.06 (-0.01, 0.13) 
  Skin D Talcum 
powder users 
0.07 (0.05, 0.09) 0.07 (0.00, 0.14) 
HRT use Ever vs. 
never  (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.09 (0.08, 0.11) 0.09 (0.08, 0.11) 
  Beauty C Frequent users 0.10 (0.09, 0.12) 0.11 (0.06, 0.16) 
 Ever vs. 
never  (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (-0.01, 
0.01) 
0.00 (-0.04, 0.03) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.08 (0.07, 0.09) 0.07 (0.01, 0.12) 
 Ever vs. 
never  (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
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  Skin B Moderate users 0.10 (0.09, 0.12) 0.08 (0.04, 0.12) 
  Skin C Frequent users 0.07 (0.05,0.09) 0.04 (-0.04, 0.11) 
  Skin D Talcum 
powder users 
0.11 (0.09,0.13) 0.06 (-0.01, 0.13) 
      
BMI 25 to 
<30kg vs 
<25kg  
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.01 (-0.01, 
0.02) 
0.01 (-0.03, 0.06) 
  Beauty C Frequent users -0.03 (-0.04, -
0.02) 
-0.08 (-0.15, -0.01) 
 ≥30kg vs 
<25kg  
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users -0.03 (-0.04, -
0.01) 
-0.07 (-0.12, -0.03) 
  Beauty C Frequent users -0.14 (-0.16, -
0.13) 
-0.19 (-0.25, -0.13) 
 25 to 
<30kg vs 
<25kg  
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (0.00, 0.01) 0.05 (0.01,  0.10) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.02 (0.01, 0.03) 0.09 (0.04,  0.14) 
 ≥30kg vs 
1<25kg  
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.01 (0.00, 0.01) 0.06 (0.02,  0.10) 
  Hair C Frequent users 
of hair 
spray/hair gel 
-0.02 (-0.04, -
0.01) 
0.04 (-0.01,  0.09) 
 25 to 
<30kg vs 
<25kg  
(ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.10 (0.06, 0.14) -0.16 (-0.43, 0.11) 
  Skin C Frequent users 0.06 (-0.01, 
0.13) 
-0.04 (-0.35, 0.28) 
  Skin D Talcum 
powder users 
-0.05 (-0.13, 
0.04) 
-0.15 (-0.45, 0.14) 
 ≥30kg vs 
1<25kg  
(ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.01 (-0.01, 
0.02) 
0.08 (0.04, 0.11) 
  Skin C Frequent users 0.04 (0.03, 0.06) 0.08 (0.02, 0.14) 
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  Skin D Talcum 
powder users 
0.01 (0.00, 0.03) 0.04 (-0.02, 0.10) 
Alcohol < 1 day vs 
never (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.06 (0.02, 0.10) 0.09 (0.01, 0.17) 
  Beauty C Frequent users -0.01 (-0.04, 
0.03) 
0.02 (-0.06, 0.09) 
 Former vs. 
never (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.20 (0.17, 0.24) 0.25 (0.18, 0.32) 
  Beauty C Frequent users 0.18 (0.14, 0.21) 0.21 (0.13, 0.29) 
 1 or 
more/day 
vs. never  
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.23 (0.2, 0.27) 0.23 (0.13, 0.33) 
  Beauty C Frequent users 0.23 (0.19, 0.26) 0.27 (0.16, 0.39) 
 < 1 day vs 
never (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.03 (0.01, 0.06) 0.00 (-0.06, 0.06) 
  Hair C Frequent users 
of hair 
spray/hair gel 
-0.04 (-0.07, -
0.01) 
-0.08 (-0.15, 0.00) 
 Former vs. 
never (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.01 (0.00, 0.02) 0.03 (0.00, 0.06) 
  Hair C Frequent users 
of hair 
spray/hair gel 
-0.06 (-0.08, -
0.05) 
-0.02 (-0.07, 0.03) 
 1 or 
more/day 
vs. never  
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (-0.01, 
0.00) 
-0.04 (-0.11, 0.02) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.01 (-0.01, 
0.02) 
0.02 (-0.07, 0.11) 
 < 1 day vs 
never (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users -0.17 (-0.2, -
0.14) 
-0.08 (-0.15, -0.01) 
  Skin C Frequent users -0.18 (-0.22, -
0.14) 
-0.18 (-0.28, -0.07) 
  Skin D Talcum 
powder users 
-0.15 (-0.19, -
0.11) 
-0.17 (-0.28, -0.06) 
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 Former vs. 
never (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users -0.13 (-0.15, -
0.12) 
-0.13 (-0.16, -0.09) 
  Skin C Frequent users -0.13 (-0.15, -
0.11) 
-0.14 (-0.20, -0.08) 
  Skin D Talcum 
powder users 
-0.10 (-0.12, -
0.08) 
-0.10 (-0.16, -0.05) 
 1 or 
more/day 
vs. never  
(ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.04 (0.03, 0.06) 0.00 (-0.07, 0.07) 
  Skin C Frequent users 0.02 (0.00, 0.04) -0.05 (-0.17, 0.08) 
  Skin D Talcum 
powder users 
0.01 (-0.02, 
0.04) 
0.00 (-0.12, 0.12) 
Smoking Past 
smoker vs 
never (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.07 (0.06, 0.08) 0.03 (-0.01, 0.07) 
  Beauty C Frequent users 0.07 (0.05, 0.08) 0.02 (-0.02, 0.07) 
 Past 
smoker vs 
never (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (-0.01, 
0.00) 
-0.03 (-0.06, 0.00) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.01 (0.00, 0.02) -0.03 (-0.08, 0.02) 
 Past 
smoker vs 
never (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.04 (0.03, 0.05) -0.03 (-0.06, 0.01) 
  Skin C Frequent users 0.04 (0.03, 0.06) -0.02 (-0.08, 0.04) 
  Skin D Talcum 
powder users 
0.04 (0.02, 0.06) -0.03 (-0.09, 0.03) 
 Current 
smoker vs 
never (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1  
  Beauty B  Moderate users 0.08 (0.06, 0.10) 0.01 (-0.04, 0.06) 
  Beauty C Frequent users -0.01 (-0.03, 
0.01) 
-0.03 (-0.10, 0.04) 
 Current 
smoker vs 
never (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.02 (0.01, 0.03) 0.00 (-0.04, 0.05) 
  Hair C Frequent users 
of hair 
spray/hair gel 
-0.02 (-0.04, -
0.01) 
-0.01 (-0.08, 0.06) 
 Current 
smoker vs 
Skin A  (ref) Infrequent 
users 
1 1 
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never (ref) 
  Skin B Moderate users -0.04 (-0.06, -
0.02) 
-0.10 (-0.15, -0.04) 
  Skin C Frequent users 0.01 (-0.01, 
0.04) 
-0.02 (-0.10, 0.06) 
  Skin D Talcum 
powder users 
0.00 (-0.03, 
0.03) 
-0.01 (-0.09, 0.07) 
Education Degree vs 
no degree 
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.04(0.03, 0.05) -0.07 (-0.11, -0.04) 
  Beauty C Frequent users 0.04 (0.03, 0.05) -0.12 (-0.16, -0.07) 
 Degree vs 
no degree 
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.02 (0.01, 0.02) 0.03 (0.01, 0.00) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.07 (0.01, 0.06) 0.00 (0.02, -0.05) 
 Degree vs 
no degree 
(ref) 
Skin A  (ref) Infrequent 
users 
1.00 1.00 
  Skin B Moderate users 0.00 (-0.01, 
0.01) 
-0.10 (-0.13, -0.06) 
  Skin C Frequent users 0.01 (-0.01, 
0.01) 
-0.09 (-0.15, -0.04) 
  Skin D Talcum 
powder users 
0.02 (0.01, 0.04) -0.09 (-0.15, -0.04) 
Family History More than 
1 sister or 
1 sister & 
mom vs 1 
sister, no 
mom (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users 0.01 (-0.01, 
0.02) 
0.00 (-0.04, 0.03) 
  Beauty C Frequent users 0.01 (0.00, 0.03) 0.03 (-0.01, 0.08) 
 More than 
1 sister or 
1 sister & 
mom vs 1 
sister, no 
mom (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
0.00 (0.00, 0.01) -0.01 (-0.04, 0.02) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.01 (0.00, 0.02) 0.03 (-0.01, 0.08) 
 More than 
1 sister or 
1 sister & 
Skin A  (ref) Infrequent 
users 
1 1 
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mom vs 1 
sister, no 
mom (ref) 
  Skin B Moderate users 0.01 (0.00, 0.02) 0.02 (-0.02, 0.06) 
  Skin C Frequent users 0.01 (-0.01, 
0.03) 
0.00 (-0.06, 0.06) 
  Skin D Talcum 
powder users 
0.01 (-0.01, 
0.03) 
0.08 (0.02, 0.14) 
Geographic 
Region 
Midwest 
vs. South 
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users -0.05 (-0.07, 
0.71) 
0.01 (-0.03, 0.05) 
  Beauty C Frequent users -0.05 (-0.06, -
0.03) 
-0.03 (-0.08, 0.03) 
 Midwest 
vs. South 
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
-0.01 (-0.02, -
0.01) 
0.02 (-0.01, 0.05) 
  Hair C Frequent users 
of hair 
spray/hair gel 
0.04 (0.03, 0.06) 0.04 (-0.01, 0.09) 
 Midwest 
vs. South 
(ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users -0.02 (-0.03, 
0.00) 
-0.02 (-0.03, 0.00) 
  Skin C Frequent users -0.03 (-0.04, -
0.01) 
-0.05 (-0.11, 0.02) 
  Skin D Talcum 
powder users 
-0.07 (-0.09, -
0.05) 
0.00 (-0.06, 0.07) 
 Northeast 
vs. South 
(ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users -0.09 (-0.11, -
0.08) 
-0.05 (-0.11, 0.01) 
  Beauty C Frequent users -0.13 (-0.14, -
0.11) 
-0.10 (-0.16, -0.03) 
 Northeast 
vs. South 
(ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
-0.02 (-0.03, -
0.01) 
-0.01 (-0.06, 0.04) 
  Hair C Frequent users 
of hair 
spray/hair gel 
-0.06 (-0.07, -
0.04) 
0.07 (-0.01, 0.14) 
 Northeast 
vs. South 
(ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users -0.06 (-0.08, -
0.05) 
-0.06 (-0.08, 0.00) 
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  Skin C Frequent users -0.05 (-0.07, -
0.03) 
-0.07 (-0.16, 0.01) 
  Skin D Talcum 
powder users 
-0.03 (-0.05, 
0.00) 
0.01 (-0.08, 0.09) 
 West vs. 
South (ref) 
Beauty A  
(ref) 
Infrequent 
users 
1 1 
  Beauty B  Moderate users -0.07 (-0.09, -
0.05) 
0.01 (-0.06, 0.07) 
  Beauty C Frequent users -0.10 (-0.11, -
0.08) 
0.02 (-0.06, 0.10) 
 West vs. 
South (ref) 
Hair A  (ref) Infrequent 
users of hair 
spray 
1 1 
  Hair B Users of 
pomade and 
hair 
straightener 
-0.01 (-0.02, -
0.01) 
-0.03 (-0.09, 0.02) 
  Hair C Frequent users 
of hair 
spray/hair gel 
-0.06 (-0.07, -
0.05) 
-0.02 (-0.09, 0.06) 
 West vs. 
South (ref) 
Skin A  (ref) Infrequent 
users 
1 1 
  Skin B Moderate users 0.03 (0.01, 0.04) 0.03 (0.01, 0.04) 
  Skin C Frequent users -0.02 (-0.05, 
0.00) 
0.05 (-0.06, 0.16) 
  Skin D Talcum 
powder users 
-0.05 (-0.08, -
0.03) 
0.05 (-0.06, 0.16) 
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Table A.7. Age-adjusted hazard ratios (HRs) and 95% confidence intervals 
(CIs) for associations between individual personal care products and breast 
cancer risk by race 
 White women  Black women  
 N(%) HR (95% CIs)* N(%) HR (95% 
CIs)* 
Beauty products     
Mascara      
Infrequent 9376 (23%) 1 1668 (41%) 1 
Moderate 8312 (20%) 1.00 (0.78, 1.22) 1217 (30%) 1.01 (0.54, 1.94) 
Frequent 23149 (57%) 1.07 (0.89, 1.28) 1218 (30%) 1.10 (0.59, 2.06) 
Eyeshadow      
Infrequent 12621 (31%) 1 1609 (39%) 1 
Moderate 18251 (44%) 1.02 (0.87, 1.22) 2121 (51%) 0.86 (0.50, 1.48) 
Frequent 10224 (25%) 0.96 (0.78, 1.17) 407 (10%) -- 
Eyeliner      
Infrequent 17523 (43%) 1 1962 (48%) 1 
Moderate 13071 (32%) 1.07 (0.92, 1.3) 1553 (38%) 0.94 (0.53, 1.65) 
Frequent 10368 (25%) 1.11 (0.94, 1.36) 590 (14%) -- 
Lip Moisturizer    
Infrequent 5236 (13%) 1 678 (16%) 1 
Moderate 12990 (32%) 1.06 (0.81, 1.29) 1184 (29%) 0.78 (0.36, 1.66) 
Frequent 22812 (56%) 1.01 (0.77, 1.2) 2251 (55%) 0.87 (0.44, 1.72) 
Lip Stick     
Infrequent 5244 (13%) 1 497 (12%) 1 
Moderate 8321 (20%) 1.02 (0.79, 1.35) 941 (23%) 0.90 (0.33, 2.45) 
Frequent 27450 (67%) 1.06 (0.82, 1.31) 2655 (65%) 1.17 (0.5, 2.77) 
Foundation      
Infrequent 10892 (27%) 1 1340 (33%) 1 
Moderate 15750 (38%) 1.14 (0.94, 1.36) 2023 (49%) 1.11 (0.61, 1.99) 
Frequent 14310 (35%) 1.07 (0.88, 1.29) 742 (18%) 0.85 (0.37, 1.92) 
Blush      
Infrequent 8835 (22%) 1 1750 (43%) 1 
Moderate 17027 (42%) 1 (0.84, 1.24) 1906 (46%) 0.97 (0.55, 1.71) 
Frequent 15133 (37%) 1.04 (0.87, 1.29) 455 (11%) 1.02 (0.44, 2.38) 
Makeup remover     
Infrequent 24639 (61%) 1 2579 (63%) 1 
Moderate 10624 (26%) 1.11 (0.9, 1.26) 1232 (30%) 0.83 (0.45, 1.5) 
Frequent 5420 (13%) 1.05 (0.85, 1.31) 270 (7%) -- 
Nail polish     
Infrequent 7201 (17%) 1 349 (8%) 1 
Moderate 16994 (41%) 0.97 (0.79, 1.19) 1668 (41%) 1.08 (0.42, 2.75) 
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Frequent 17305 (42%) 0.96 (0.79, 1.19) 2099 (51%) 0.87 (0.34, 2.2) 
Nail polish remover     
Infrequent 7757 (19%) 1 399 (10%) 1 
Moderate 17821 (43%) 0.99 (0.82, 1.22) 1717 (42%) 0.73 (0.33, 1.61) 
Frequent 15947 (38%) 1.01 (0.82, 1.23) 1995 (49%) 0.63 (0.29, 1.4) 
Artificial nails    
Infrequent 35014 (86%) 1 3064 (75%) 1 
Moderate 1873 (5%) 1.13 (0.75, 1.5) 475 (12%) -- 
Frequent 3811 (9%) 1.08 (0.85, 1.39) 562 (14%) 0.89 (0.4, 1.97) 
Artificial nails (other)     
Infrequent 39412 (99%) 1 3919 (96%) 1 
Moderate 215 (0.5%) 1.61 (0.62, 3.62) 98 (2%) -- 
Frequent 122 (0.3%) 0.85 (0.21, 3.96) 47 (1%) -- 
Perfume      
Infrequent 8492 (21%) 1 377 (9%) 1 
Moderate 14120 (34%) 1.01 (0.84, 1.26) 1119 (27%) 1.14 (0.42, 3.09) 
Frequent 18493 (45%) 1.02 (0.86, 1.27) 2618 (64%) 1.10 (0.43, 2.82) 
Cuticle cream    
Infrequent 21509 (53%) 1 1547 (38%) 1 
Moderate 12541 (31%) 1.11 (0.94, 1.31) 1557 (38%) 1.02 (0.57, 1.81) 
Frequent 6854 (17%) 1.07 (0.87, 1.31) 996 (24%) 0.70 (0.34, 1.44) 
Hair products    
Shampoo      
Infrequent 1188 (3%) 1 2945 (72%) 1 
Moderate 21751 (54%) 1.12 (0.67, 1.58) 1031 (25%) 1.05 (0.57, 1.9) 
Frequent 17525 (43%) 1.22 (0.73, 1.76) 119 (3%) -- 
Conditioner      
Infrequent 8350 (21%) 1 450 (11%)  
Moderate 4022 (10%) 0.95 (0.71, 1.24) 2562 (63%) 1.24 (0.5, 3.08) 
Frequent 28245 (70%) 0.97 (0.79, 1.13) 1081 (26%) 1.16 (0.43, 3.14) 
Hair spray     
Infrequent 10449 (25%) 1 1755 (43%) 1 
Moderate 10099 (25%) 1.07 (0.87, 1.3) 1806 (44%) 0.99 (0.57, 1.72) 
Frequent 20561 (50%) 0.94 (0.79, 1.13) 553 (13%) -- 
Hair gel     
Infrequent 9420 (23%) 1 1738 (42%) 1 
Moderate 10615 (26%) 1.07 (0.83, 1.25) 1696 (41%) 1.08 (0.62, 1.89) 
Frequent 20717 (51%) 1.07 (0.88, 1.27) 671 (16%) 0.75 (0.32, 1.72) 
Pomade      
Infrequent 36510 (91%) 1 1139 (28%) 1 
Moderate 2022 (5%) 0.97 (0.7, 1.4) 1816 (44%) 0.91 (0.48, 1.73) 
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Frequent 1411 (4%) 0.89 (0.63, 1.46) 1158 (28%) 1.08 (0.55, 2.13) 
Permanent hair dye     
Infrequent 17898 (48%) 1 21461 (49%) 1 
Moderate 9425 (26%) 1.06 (0.86, 1.27) 11518 (26%) 1.31 (0.71, 2.42) 
Frequent 9633 (26%) 1.09 (0.86, 1.26) 10781 (25%) 1.97 (0.92, 4.2) 
Semi-permanent hair 
dye 
    
Infrequent 33792 (84%) 1 2645 (67%) 1 
Moderate 2538 (6%) 1.02 (0.74, 1.37) 560 (14%) 1.46 (0.72, 2.98) 
Frequent 3681 (9%) 0.85 (0.63, 1.1) 717 (18%) 1.01 (0.49, 2.09) 
Hair highlighter    
Infrequent 27156 (67%) 1 3689 (91%) 1 
Moderate 5791 (14%) 1.05 (0.81, 1.26) 302 (7%) -- 
Frequent 7765 (19%) 1.04 (0.86, 1.26) 82 (2%) -- 
Hair straightener     
Infrequent 38806 (98%) 1 1045 (29%) 1 
Moderate 718 (2%) 1.03 (0.59, 1.92) 1189 (33%) 1 (0.48, 2.06) 
Frequent 84 (0%) -- 1345 (38%) 1.15 (0.57, 2.33) 
Hair straightener 
(other) 
    
Infrequent 39518 (99%) 1 3156 (79%) 1 
Moderate 224 (0.6%) -- 475 (12%) 1.35 (0.62, 2.91) 
Frequent 70 (0.2%) -- 342 (9%) -- 
Hair color rinse    
Infrequent 38324  (95%) 1 2929 (75%) 1 
Moderate 1181  (3%) -- 465 (12%) -- 
Frequent 846  (2%) -- 500 (13%) -- 
Hair food     
Infrequent 39221  (98%) 1 2610 (64%) 1 
Moderate 297  (1%) 0.7 (0.35, 2.18) 755 (18%) 1.23 (0.64, 2.34) 
Frequent 252  (1%) 0.74 (0.28, 2.25) 745 (18%) 0.75 (0.35, 1.63) 
Hair bleach     
Infrequent 35201  (88%) 1 3846 (95%) 1 
Moderate 1851  (5%) 0.93 (0.69, 1.42) 146 (4%) -- 
Frequent 3000  (7%) 1.02 (0.71, 1.27) 54 (1%) -- 
Hair perm     
Infrequent 36128  (87%) 1 3120 (78%) 1 
Moderate 2885  (7%) 0.91 (0.7, 1.24) 220 (5%) -- 
Frequent 2435  (6%) 0.92 (0.71, 1.29) 664 (17%) 1.3 (0.68, 2.49) 
Rogaine     
Infrequent 39066  (98%) 1 3960 (97%) 1 
Moderate 106  (0.3%) -- 25 (1%) -- 
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Frequent 532  (1%) 0.87 (0.54, 1.88) 78 (2%) -- 
Skincare products     
Cleansing cream     
Infrequent 21018 (51%) 1 1688 (41%) 1 
Moderate 6738 (16%) 1.07 (0.86, 1.29) 995 (24%) 0.76 (0.37, 1.52) 
Frequent 13185 (32%) 0.96 (0.78, 1.1) 1439 (35%) 1.01 (0.56, 1.81) 
Blemish     
Infrequent 31716 (77%) 1 3002 (73%) 1 
Moderate 4256 (10%) 1.10 (0.89, 1.44) 406 (10%) -- 
Frequent 5147 (13%) 1.24 (0.97, 1.51) 699 (17%) 1.04 (0.5, 2.15) 
Face cream     
Infrequent 5168 (13%) 1 938 (23%) 1 
Moderate 8283 (20%) 1.06 (0.8, 1.34) 1220 (29%) 0.86 (0.4, 1.82) 
Frequent 27885 (67%) 1.05 (0.79, 1.22) 1980 (48%) 1.04 (0.54, 1.99) 
Face mask     
Infrequent 26043 (63%) 1 2372 (58%)  
Moderate 11789 (29%) 1.08 (0.91, 1.26) 1156 (28%) 0.91 (0.5, 1.66) 
Frequent 3340 (8%) 1.08 (0.78, 1.36) 588 (14%) 1 (0.47, 2.13) 
Shaving cream    
Infrequent 22273 (55%) 1 2408 (59%) 1 
Moderate 5724 (14%) 1.00 (0.80, 1.24) 794 (19%) 1 (0.51, 1.97) 
Frequent 12871 (31%) 1.00 (0.84, 1.17) 886 (22%) 0.94 (0.46, 1.88) 
Anti-aging cream     
Infrequent 17038 (42%) 1 2669 (65%) 1 
Moderate 7542 (19%) 1.00 (0.82, 1.24) 671 (16%) 0.84 (0.39, 1.8) 
Frequent 16151 (40%) 1.08 (0.9, 1.24) 771 (19%) 1.09 (0.57, 2.07) 
Age spot remover     
Infrequent 35111 (87%) 1 3465 (84%) 1.00 (0.43, 2.07) 
Moderate 4174 (10%) 0.95 (0.78, 1.27) 526 (13%) 0.94 (0.09, 4.05) 
Frequent 910 (2%) 0.67 (0.38, 1.23) 117 (3%) -- 
Self-tanner     
Infrequent 28688 (70%) 1 3940 (96%) 1 
Moderate 6762 (17%) 0.98 (0.8, 1.2) 90 (2%) -- 
Frequent 5363 (13%) 0.91 (0.72, 1.14) 62 (2%) -- 
Baby oil     
Infrequent 31752 (77%) 1 1715 (42%) 1 
Moderate 6796 (17%) 1.02 (0.85, 1.26) 1387 (34%) 0.62 (0.33, 1.17) 
Frequent 2623 (6%) 0.84 (0.59, 1.13) 1019 (25%) 0.79 (0.41, 1.5) 
Petroleum Jelly    
Infrequent 28273 (69%) 1 1392 (34%) 1 
Moderate 8465 (21%) 0.93 (0.76, 1.11) 1465 (36%) 1.12 (0.60, 2.10) 
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Frequent 4345 (11%) 1.00 (0.8, 1.26) 1269 (31%) 1.15 (0.61, 2.18) 
Body lotion     
Infrequent 4679 (12%) 1 259 (6%) 1 
Moderate 16445 (40%) 1.03 (0.77, 1.23) 1125 (27%) 0.80 (0.30, 2.10) 
Frequent 19522 (48%) 0.96 (0.73, 1.15) 2718 (66%) 0.63 (0.25, 1.57) 
Hand lotion     
Infrequent 7016 (17%) 1 371 (9%) 1 
Moderate 11838 (29%) 0.99 (0.78, 1.2) 929 (23%) 0.64 (0.25, 1.63) 
Frequent 22109 (54%) 0.90 (0.73, 1.08) 2808 (68%) 0.64 (0.29, 1.44) 
Foot cream     
Infrequent 12034 (30%) 1 680 (17%) 1 
Moderate 16837 (41%) 1.02 (0.85, 1.2) 1351 (33%) 0.89 (0.42, 1.86) 
Frequent 11893 (29%) 0.89 (0.74, 1.08) 2082 (51%) 0.75 (0.37, 1.51) 
Deodorant     
Infrequent 3347 (8%) 1 134 (3%) 1 
Moderate 4406 (11%) 1.02 (0.67, 1.33) 354 (9%) --  
Frequent 33720 (81%) 1.15 (0.82, 1.41) 3651 (88%) 1.44 (0.27, 7.67) 
Infrequent 34014 (84%) 1 3430 (83%) 1 
Talcum underarms     
Moderate 3074 (8%) 0.87 (0.69, 1.22) 354 (9%) -- 
Frequent 3496 (9%) 0.81 (0.65, 1.12) 333 (8%) -- 
Talcum other    
Infrequent 25798 (63%) 1 2541 (62%) 1 
Moderate 7107 (17%) 0.97 (0.81, 1.2) 614 (15%) 0.79 (0.37, 1.7) 
Frequent 8086 (20%) 0.91 (0.77, 1.12) 969 (24%) 0.73 (0.37, 1.41) 
Talcum vaginal    
Infrequent 34746 (86%) 1 3318 (81%) 1 
Moderate 2618 (6%) 0.87 (0.59, 1.13) 280 (7%) --  
Frequent 3158 (8%) 0.93 (0.76, 1.31) 522 (13%) 0.93 (0.42, 2.06) 
Bath gel     
Infrequent 12111 (30%) 1 483 (12%) 1 
Moderate 12304 (30%) 1.11 (0.9, 1.31) 1158 (28%) 1.27 (0.51, 3.16) 
Frequent 16551 (40%) 1.07 (0.85, 1.21) 2464 (60%) 1.12 (0.48, 2.63) 
Skin lightener    
Infrequent 38467 (96%) 1 3400 (83%) 1 
Moderate 524 (1%) 1.24 (0.79, 1.27) 221 (5%) -- 
Frequent 922 (2%) 0.94 (0.56, 1.58) 476 (12%) -- 
*Confidence intervals adjusted for Bonferroni criteria (p-value<0.001) 
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